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ABBREVIATIONS 
(p)ppGpp guanosine penta- or tetraphosphate  
ADP adenosine diphosphate 
ATP adenosine triphosphate 
chr I the larger chromosome of Vibrio cholerae, contains most of the 
essential genes (about 2.96 Mbp) 
chr II the smaller chromosome of Vibrio cholerae, contains very few 
essential genes (about 1.07 Mbp) 
GTP guanosine triphosphate 
ITC isothermal titration calorimetry 
LB lysogeny broth 
PCD programmed cell death 
PI propidium iodide, a DNA binding stain that can permeate only 
damaged membranes 
PSK post segregational killing 
SD Shine-Dalgarno sequence 
TA toxin-antitoxin  
WT wild-type 
 
 
Origin of the names of type II TA systems mentioned in the thesis 
ChpB chromosomal homologue of Pem, ChpBK – toxin, 
ChpBI – cognate antitoxin. 
CcdAB coupled cell division. CcdB – toxin, CcdA – cognate antitoxin 
DinJ/YafQ damage-inducible, YafQ – systematic nomenclature, toxin, 
DinJ – cognate antitoxin.  
GraTA growth-rate-affecting, GraT – toxin, GraA – cognate antitoxin. 
HipBA high persistence protein, HipA – toxin, HipB – cognate antitoxin. 
HigAB host inhibition of growth; HigB – toxin, 
HigA – cognate antitoxin. 
HicAB hif contiguous (homologues of Haemophilus influenza hif locus); 
HicA – toxin, HicB – antitoxin. 
Kis/Kid Kid – Killing determinant, toxin, Kis – a suppressor of killer, 
cognate antitoxin. 
MazEF “ma-ze” means “What is it?” in Hebrew, MazF – toxin, 
MazE – cognate antitoxin. 
MosAT maintenance of SXT, MosT – toxin, MosA – cognate antitoxin. 
MqsRA MqsR – motility quorum-sensing regulator, toxin, 
MqsA – cognate antitoxin. 
ParDE derived from the word partition, ParE – toxin, 
ParD – cognate antitoxin. 
PezAT PezT – pneumococcal epsilon zeta toxin,  
PezA – cognate antitoxin. 
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Phd/Doc Doc – death on curing, toxin, 
Phd – prevents host death, antitoxin. 
RatA ribosome association toxin. 
RelBE derived from the ‘delayed-relaxed’ phenotype (mutations in relE 
cause a lag before stable RNA synthesis continues after inducing 
amino acid starvation). RelE – toxin, RelB – cognate antitoxin. 
RnlAB RNase LS (late gene silencing in T4), RnlA – toxin, 
RnlB – cognate antitoxin. 
TalAB TA (toxin-antitoxin) of Lxc (Leifsonia xyli subsp. cynodontis), 
TalB – toxin, TalA – cognate antitoxin. 
VapBC virulence associated protein, VapC – toxin; 
VapB – cognate antitoxin. 
YafNO systematic nomenclature. YafO – toxin, 
YafN – cognate antitoxin. 
YefM/YoeB systematic nomenclature. YoeB – toxin, 
YefM – cognate antitoxin. 
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INTRODUCTION 
Life is full of stress. This is true for us, but even more so for unicellular 
organisms like bacteria. Bacteria inhabit a wide variety of different environ-
ments and often encounter very diverse stress conditions. During stress the most 
convenient thing for us sometimes seems to be curling up, doing nothing and 
waiting for things to get better. A similar strategy is also used by bacteria – 
upon stress conditions their growth rate decreases and dormancy is induced 
(Lewis, 2007). This helps bacteria to survive under unfavourable conditions and 
resume growth after the stress has passed (Tuomanen, et al., 1986, Eng, et al., 
1991). Many different growth rate regulating mechanisms have evolved that 
help bacteria cope with stress (Starosta, et al., 2014). In my thesis, I will focus 
on a recently recognized mechanism of stress tolerance – the potentially 
poisonous bacterial toxin-antitoxin (TA) systems. 
As a general rule, these systems consist of two counterparts – a toxin that 
inhibits some major process or compartment of the cell, and an antitoxin that is 
able to counteract the harmful effect of the toxin (Buts, et al., 2005). At first, 
these potentially noxious modules were discovered in plasmids, where they are 
important for maintaining the plasmid in the bacterial population (Gerdes, et al., 
1986a). Later on they were also found to be abundant in the bacterial chromo-
somes (Pandey & Gerdes, 2005). The importance of chromosomal TA modules 
has been a subject of debate ever since their discovery as it seems incomprehen-
sible for a living organism to produce a self-poisoning protein. Yet, recent 
results have associated the chromosomal TA systems not only with growth and 
dormancy of bacteria, but also with other stress responses, suggesting their 
involvement in virulence modulation, phage protection, biofilm formation and 
general stress response (Gerdes, et al., 2005). 
The participation of TA systems in stress management was first proposed 
because of their uneven distribution among bacteria from different habitats. 
There are numerous TA systems in the chromosomes of environmental and 
pathogenic species, i.e. in bacteria that frequently encounter different stressful 
conditions during their life (Pandey & Gerdes, 2005). In intracellular bacteria, 
on the other hand, none or a few systems are present, suggesting that in stable 
environments TA systems lose their importance and respective genes are 
eliminated from the genome (Pandey & Gerdes, 2005). Yet, although in recent 
years the TA systems have been extensively studied, their biological importance 
and a precise role in bacterial stress tolerance has remained a subject of debate. 
The natural habitat of the environmental bacterium Pseudomonas putida is 
very varying, necessitating the need for different mechanisms to survive the 
potentially encountered stress conditions (Silby, et al., 2011). Therefore, it is 
not surprising that this bacterium encodes many TA modules in its chromosome 
(Shao, et al., 2011). Yet, when I started my PhD studies, only limited knowledge 
about the TA systems in this bacterium was available. The intriguing finding 
that a disruption of a putative antitoxin gene PP1585 leads to the alleviation of 
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membrane stress of bacteria deficient in the ColRS two-component system 
(Putrinš, et al., 2011) led us to study that TA system in P. putida more closely 
to determine its involvement in suppression of the membrane stress of colR-
deficient bacteria as well as its overall role in the physiology and stress 
management of P. putida. 
The first part of this thesis gives an overview of the current knowledge about 
the variability of different TA systems: their mechanisms of action as well as 
the involvement of the chromosomal TA modules in the physiology and stress 
regulation of different bacteria. The experimental part of the thesis focuses on 
the characterization of the growth-rate-affecting GraTA system, which is the 
first well-described TA system in P. putida and possesses several unusual 
features not present in other TA systems.  
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REVIEW OF LITERATURE 
1. General traits of toxin-antitoxin systems 
Toxin-antitoxin (TA) systems are widespread in the prokaryotic world (Pandey 
& Gerdes, 2005). In general, bacterial TA systems, as the name suggests, 
consist of two counterparts: a toxin and an antitoxin. The toxin influences cell 
growth by targeting major processes and compartments like translation, 
replication, cell wall or membrane. Under normal conditions the activity of the 
toxin is inhibited by the other component of the system – the antitoxin. There 
are also a few unconventional systems that are composed of three counterparts 
(Zielenkiewicz & Ceglowski, 2005, Hallez, et al., 2010, Melnicakova, et al., 
2015) and so far just one TA module has been described that has both activities 
in one molecule (Rocker & Meinhart, 2015). The activation of a TA system 
requires either increased expression of the toxin or decreased ability of the 
antidote to inhibit the toxin. The latter is most often achieved by triggering the 
degradation of the antitoxin (Brzozowska & Zielenkiewicz, 2013). As a result, 
the stable toxin is released from the antitoxin’s inhibition, and can exert the 
poisonous effect on its target(s) thereby influencing the life of the host 
bacterium. 
TA systems can be encoded on plasmids as well as on chromosomes. At 
first these small modules were discovered from low-copy number plasmids 
where they function as plasmid maintenance systems through a mechanism 
known as post-segregational killing (PSK) (Ogura & Hiraga, 1983, Gerdes, et 
al., 1986b, Gerdes, et al., 1986a) (Fig 1). In a stable system, when bacterium 
harbours the TA-encoding plasmid, both the toxin and antitoxin are produced. 
The antitoxin prevents the activation of the toxin, for example, by complex 
formation. Although the antitoxin is labile, it can be produced from the plasmid. 
Yet, unequal distribution of plasmids during cell division may result in daughter 
cells without the plasmid and, thus, disability to produce either toxin or 
antitoxin. However, the TA proteins are inherited through the cytoplasm and as 
antitoxins are degraded faster than toxins, the toxins are freed from the 
antitoxin-mediated inhibition. Most toxins act in a bacteriostatic manner, but 
they can also have an irreversible effect and kill the cells. Nonetheless, 
irrespective of whether the toxin effect is bactericidal or bacteriostatic, the 
plasmid-free cells are eventually outcompeted from the population (Gerdes, et 
al., 1986a) (Fig 1). 
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Figure 1. The PSK mechanism of plasmid-borne TA systems. Unequal cell-division 
leads to cells without the TA-encoding plasmid. TA proteins are still inherited via 
cytoplasm. Labile antitoxins are degraded and more stable toxins are activated and 
inhibit the growth of the cells (or kill them). Consequently, only the cells with the 
plasmid remain in the population. Antitoxin is marked with blue, toxin with red colour 
 
2. Diversity of the TA systems 
In recent years the research and knowledge on TA systems has largely 
expanded. For clarity, the TA systems have been divided into six types by the 
nature and inhibitory mechanism of the antitoxin (Page & Peti, 2016). The 
antitoxins may be either small RNAs (the TA types I and III) or proteins (types 
II, IV, V and VI), and the mechanisms of toxin inactivation vary largely as well. 
Antitoxins can inhibit toxins’ synthesis (types I and V) (Fozo, et al., 2008, 
Wang, et al., 2012), activity (types II and III) (Marianovsky, et al., 2001, Fineran, 
et al., 2009), stability (type VI) (Aakre, et al., 2013) or stabilize the toxins’ 
target (type IV) (Masuda, et al., 2012). The most prevalent and thoroughly 
studied are TA systems of type I and II, while others are represented by only a 
few examples. Still, more and more experimental data now emerge for other TA 
types as well. 
 
 
2.1. Type I TA systems 
In type I TA systems, the antitoxins are sRNAs that inhibit the translation of the 
toxin (Fig 2). The RNA antitoxins are complementary to the toxin mRNAs and 
by binding them, they prevent the toxin synthesis. Some RNA antitoxins, like 
IstR, inhibit ribosome binding to toxin mRNA (Darfeuille, et al., 2007), but 
others, like RatA, induce the toxin’s mRNA degradation (Silvaggi, et al., 2005). 
There are also antitoxins, for example SprF1 and SR4 that act by combining 
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both mechanisms (Jahn & Brantl, 2013, Pinel-Marie, et al., 2014). As the 
inhibition of toxins takes place before the protein production, this kind of toxin 
suppression could be beneficial in the case where toxin is harmful for bacteria 
already at a very low concentration. 
 
 
Figure 2. Type I TA system. The toxin protein, usually targeting the membrane, is 
inhibited at a pretranslational level by sRNA antitoxin that binds the toxin mRNA and 
(usually) promotes its degradation. The antitoxin is depicted in blue and the toxin in red. 
 
Type I systems can be activated either by the antitoxin sRNA degradation (Jahn, 
et al., 2012) or by the induction of toxin expression (13). For instance, the 
activity of the BsrG-SR4 system is regulated by the different stability of the 
counterparts (Jahn, et al., 2012). TisB-IstR system, on the other hand, is under 
the control of a global regulator, the LexA repressor (Wagner & Unoson, 2012). 
During the DNA damage-induced SOS response when LexA is degraded, the 
rapid transcription of tisB mRNA outcompetes the IstR antitoxin and the TisB 
toxin is produced. The production of TisB decreases only after the SOS-
conditions have passed (Wagner & Unoson, 2012). 
Most commonly, the toxins of type I TA systems are small hydrophobic 
pore-forming peptides that damage the bacterial membrane. An illustrative 
representative of such toxins is the Hok toxin from the Hok-Sok system. This 
system was one of the first type I system to be discovered – it was initially 
found from E. coli R1 plasmid (Gerdes, et al., 1986b, Gerdes, et al., 1986a). 
Later, similar loci were identified in chromosomes of bacteria as well (Pedersen 
& Gerdes, 1999). The Hok toxin is a small peptide that targets the cell 
membrane and increases its permeability. As a result, the proton motive force 
required for ATP synthesis is decreased and the growth of bacteria inhibited 
(Gerdes, et al., 1986b). Another type I TA module, that also encodes a pore-
forming peptide, is the tisB-istR locus (Unoson & Wagner, 2008). As in case of 
the Hok toxin, the membrane becomes permeabilized and the cellular energy 
level decreased when TisB is produced (Gurnev, et al., 2012). 
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Pore-forming is not the only way that type I systems use to damage the 
bacterial membrane. For example, the toxin BsrG of the bsrG/SR4 system 
disturbs the synthesis of the cell envelope, but causes neither membrane 
permeabilization nor energy starvation as the pore-forming toxins do (Jahn, et 
al., 2015). The effects of type I toxins are even more diverse because some 
membrane-spanning toxins, e.g. Fst, have also been shown to cause nucleoid 
condensation (Kawano, et al., 2002, Patel & Weaver, 2006, Weaver, et al., 
2009). 
Recent studies have revealed that the type I toxins can be divided into two 
distinct groups according to their localisation and mechanisms of action 
(Brielle, et al., 2016). While most of the described toxins are representatives of 
the membrane-associated proteins, the smaller group of toxins is comprised of 
cytosolic proteins that cleave nucleic acids. For instance, the toxin encoded by 
the ralR-ralA locus cleaves DNA (Guo, et al., 2014). There is also one type I 
toxin, SymE, which resembles the MazF toxin from the type II TA system and 
acts as an endoribonuclease (Kawano, et al., 2007). Therefore, although the 
majority of type I TA toxins disturb the bacterial cell membrane, a great variety 
in this type of TA systems exists and toxins may have very different targets and 
mechanisms of action. 
 
 
2.2. Type II TA systems 
An entirely different form of TA systems is the type II TA module in which 
both components are proteins. The type II systems are extremely widespread in 
the prokaryotic world and are the most thoroughly studied among the TA 
systems. Although the extensive research has revealed a striking diversity of 
type II systems, most of them still share several common features: (i) TA genes 
are adjacent and encoded by the same operon; (ii) both the toxin and antitoxin 
are small proteins; (iii) the toxin’s activity is inhibited by the antitoxin binding; 
(iv) the antitoxin and/or the TA complex usually acts as an autorepressor of the 
operon; and (v) the mechanism of action of these systems is based on the higher 
stability of the toxin compared to its antidote (Gerdes & Maisonneuve, 2012). 
Figure 3 shows the mechanism of action of a typical type II TA system, yet 
many exceptions apply for distinct systems. As type II TA proteins are the main 
focus of this thesis, next chapters will describe this group of TA systems more 
comprehensively. 
 
16 
 
 
Figure 3. A typical type II TA system. The TA genes are coded by one locus, the 
antitoxin gene usually preceding the toxin gene. The operon is autorepressed by the 
antitoxin and/or the TA complex. In complex with the antitoxin, the toxin is inactive. 
The stable toxins will be activated when labile antitoxins are degraded by cellular 
proteases. Toxins inhibit major cellular processes such as translation and replication. 
The promoter is depicted in green, antitoxin in blue and toxin in red. 
 
 
2.2.1. Regulation of Type II TA systems 
Type II TA systems are regulated at two levels. Firstly, the production of both 
counterparts is regulated at transcriptional level. Secondly, the activity of the 
toxin is regulated post-translationally, by modulating the stability of the 
antitoxin. 
 
2.2.1.1. Transcriptional regulation 
The toxin and antitoxin genes of a type II TA system belong to the same operon 
where the antitoxin gene is usually the first, followed by the toxin gene (Fig 3). 
This gene organization has been suggested to ensure a higher production of the 
antitoxin compared to the toxin (Gerdes, et al., 2005). Still, some systems, like 
the HigBA (Christensen-Dalsgaard & Gerdes, 2006), HicAB (Jorgensen, et al., 
2009), MqsRA (Christensen-Dalsgaard, et al., 2010, Kasari, et al., 2010) and 
RnlAB (Otsuka, et al., 2010), have a reversed order of genes, with the toxin 
gene preceding the antitoxin. The higher production of the antitoxin in these 
cases can be achieved with an additional promoter in front of the antitoxin gene, 
as has been suggested for higA (Tian, et al., 1996b) from the Rts-1 plasmid of 
Proteus vulgaris and rnlB (Otsuka, et al., 2010) from the E. coli chromosome. 
The additional promoter in front of the higA is weaker than the one in front of the 
higBA operon, but the rnlB promoter is about eightfold stronger than the promoter 
in front of the rnlAB operon (Otsuka, et al., 2010), so the higher expression of the 
antitoxin would be guaranteed. For mqsRA and hicAB systems, no additional 
promoter in front of the antitoxin gene has been found (Jorgensen, et al., 2009, 
Christensen-Dalsgaard, et al., 2010, Bibi-Triki, et al., 2014). 
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The antitoxins usually contain a DNA-binding domain and act as 
transcriptional regulators by repressing the expression of their own operon. 
Interestingly, not only the antitoxin alone but also the TA complex can act as an 
autorepressor of the TA genes (Fig 3). For many type II systems, a regulatory 
mechanism has been observed, where the effect of the TA proteins on the 
promoter depends on the ratio between the toxin and antitoxin. Such regulation 
is termed conditional cooperativity (Overgaard, et al., 2008) as the transcription 
is cooperatively repressed by both TA proteins only under certain conditions. 
For example, repression of the relBE operon is the strongest, when the anti-
toxin:toxin ratio is 2:1, whereas higher levels of the RelE toxin result in 
derepression of the TA promoter (Cataudella, et al., 2012). A similar 
transcriptional regulation has been observed for many other type II TA systems 
as well: the strongest repression is usually achieved in the 1:1 ratio of the toxin 
and antitoxin, whereas derepression is seen when the proportion of the toxin 
increases over this level. Thus, the excess of the toxin results in higher 
expression of the TA operon and production of the antitoxin. When proteases 
are active, the produced antitoxin is degraded rapidly, but when the proteases 
become inactive, the antitoxin amount is quickly restored to the level needed to 
inhibit the toxin present in excess (Loris & Garcia-Pino, 2014). 
Some type II TA systems have other mechanisms of transcription control. 
For example, the TalAB system of Leifsonia xyli subsp. cynodontis is regulated 
in an entirely opposite manner. For this system, the toxin is the protein with the 
DNA-binding domain (Cheng, et al., 2008). However, without the antitoxin, the 
binding of the toxin to DNA is extremely weak, addition of the antitoxin 
enhances the protein’s binding to the DNA, indicating that repression is actually 
carried out by the TA complex. Thus, this system represents an exceptional type 
of regulation with a reversed functionality of the two TA proteins (Cheng, et al., 
2008). 
There are also other type II TA modules, where antitoxin and toxin do not 
exhibit cooperative binding to the promoter. For example, the transcription of 
mqsRA system of E. coli is autorepressed by the antitoxin MqsA only and the 
toxin acts as a derepressor, irrespective of the ratio between the two proteins 
(Brown, et al., 2013). Also, the affinity of the DinJ/YafQ complex to the 
promoter DNA is similar to that of the antitoxin DinJ alone (Ruangprasert, et 
al., 2014) indicating that the YafQ toxin does not affect the DinJ binding 
activity. For the HicAB system, it remains unclear whether the regulation 
resembles the MqsRA system or is mediated by conditional cooperativity (Bibi-
Triki, et al., 2014). There are also type II TA systems that are not autoregulated 
by TA proteins at all. For instance, the unconventional three-component system 
ω-ε-ζ is regulated neither by the epsilon antitoxin nor the zeta toxin, but by an 
omega protein, encoded in the same operon (de la Hoz, et al., 2000). Neither is 
the expression of the mazEF-Sa locus from Staphylococcus aureus 
autoregulated by the TA proteins but rather controlled by transcription 
regulators SarA and σB (Donegan & Cheung, 2009). All in all, although 
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conditional cooperativity is the most common mechanism of type II TA 
operons’ regulation, the high number of type II systems means that also many 
different regulation mechanisms are applied in their expression. 
 
2.2.1.2. Post-translational regulation 
Besides the transcriptional regulation, the activity of the toxin is controlled by 
the stability of the antitoxin protein. Activation of the type II toxins is mostly 
achieved by degradation of antitoxins by stress-induced proteases Lon or ClpP 
(Brzozowska & Zielenkiewicz, 2013). Commonly, the antitoxins are quite 
unstable proteins with half-lives mostly around 15 minutes (Christensen, et al., 
2001, Ning, et al., 2011, Hansen, et al., 2012). Therefore, the antidote proteins 
need to be constantly produced to ensure the inhibition of the toxin. Structural 
analysis of antitoxins has revealed that besides well-ordered DNA binding 
domains, many type II antitoxins, e.g. MazE, Kid and HipB, contain an un-
structured toxin-binding domain (Loris, et al., 2003, Kamphuis, et al., 2007, 
Schumacher, et al., 2009). While the disordered nature of the antidote proteins 
makes them available substrates for cellular proteases (Gazit & Sauer, 1999, 
Loris, et al., 2003, Kamphuis, et al., 2007, Hansen, et al., 2012, Brzozowska & 
Zielenkiewicz, 2013), the TA complex formation usually stabilizes the anti-
toxins as the flexible parts form a more ordered structure (Kamada, et al., 
2003), or become masked from proteases by the toxins (Schumacher, et al., 
2009). In stressful conditions, when the activity of ATP-dependent proteases 
increases, the ratio of toxin:antitoxin changes in favour of the toxins. This 
results not only in toxin activation and growth suppression, but also in 
derepression of the TA operon. In this way a transient activation of the toxin is 
achieved, while the conditional cooperativity mechanism guarantees that in case 
of surplus accumulation of the toxin, the expression of the TA proteins will be 
increased again. Once the stress is over, the inactivation of proteases leads to 
the stabilization of the antitoxin, and eventually the excess toxin can be 
inactivated again by complex formation. When the toxin:antitoxin ratio be-
comes normalized, the production of TA proteins is further repressed at the 
transcriptional level (Loris & Garcia-Pino, 2014). 
Bearing in mind the diversity of the type II TA systems, it is not surprising 
that some exceptions regarding antitoxin instability exist. For example, the 
antitoxin MqsA is a quite stable protein in growth-favouring conditions. This is 
probably due to its more structured nature compared to other type II antitoxins 
(Brown, et al., 2009). Yet, under oxidative stress conditions, the degradation 
rate of MqsA accelerates, the half-life of the protein dropping from one hour to 
just one minute (Wang, et al., 2011). Hence, this system represents another 
model of regulation, where the constant production of MqsA is not crucial and 
antitoxin’s degradation is triggered only under distinct stress conditions. In 
compliance with that, as already mentioned, the regulation of mqsRA expression 
does not involve conditional cooperativity (Brown, et al., 2013). 
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2.2.1.3. Activation by stress conditions 
While the MqsRA in E. coli is activated upon oxidative stress (Kwan, et al., 
2015), many other systems are activated by a variety of signals. For example, 
nutrition starvation, oxidative stress, different antibiotics, attack by bacterio-
phages and other stress factors can trigger the activation of many TA systems 
(Hazan, et al., 2004, Ramage, et al., 2009, Christensen-Dalsgaard, et al., 2010, 
Otsuka & Yonesaki, 2012). Considering that in E. coli most type II antitoxins 
are degraded by Lon or Clp proteases (Brzozowska & Zielenkiewicz, 2013), it 
is expected that conditions leading to the activation of these proteases also lead 
to the activation of many TA systems (Brzozowska & Zielenkiewicz, 2013). It 
has been shown that accumulation of the stringent response alarmone (p)ppGpp 
results in the activation of Lon and Clp (Germain, et al., 2015). There are two 
enzymes that control (p)ppGpp production, RelA and SpoT. RelA induces the 
production of (p)ppGpp in response to amino acid starvation (Hauryliuk, et al., 
2015) whereas SpoT is probably more important in many other kinds of 
stresses, like carbon, iron or fatty acid starvation (Xiao, et al., 1991, Seyfzadeh, 
et al., 1993, Vinella, et al., 2005). Thus, the levels of (p)ppGpp in cells increase 
in stressful conditions and, at least in E. coli, lead to the activation of Lon and 
Clp. Thereby antitoxin degradation is increased, toxins are liberated and TA 
operon transcription is derepreressed (Germain, et al., 2015) (see also chapter 
4.2.3.). 
Besides already mentioned stress signals, TA systems are also activated in 
other stress conditions. The SOS response has been shown to trigger several 
type II TA systems, e.g. YafNO, YafQ/DinJ and MazEF (Hazan, et al., 2004, 
Prysak, et al., 2009, Christensen-Dalsgaard, et al., 2010). Also, exposure to dif-
ferent antibiotics activates certain TA systems such as YafNO, HigBA, HicAB, 
RelBE and YoeB/YefM (Sat, et al., 2001, Kohanski, et al., 2007, Jorgensen, et 
al., 2009, Christensen-Dalsgaard, et al., 2010). As normal functioning of a type 
II TA system needs constant production of the antitoxin, it is easily comprehen-
sible that inhibition of protein synthesis in general leads to the decrease in 
antitoxin levels and therefore also to derepression of TA operons and activation 
of the toxins. As described in the next chapter, many type II toxins inhibit 
translation. Thus, activation of one TA system can contribute to the activation 
of others. 
In E. coli, the stress-induced regulation has been extensively studied and 
well characterized, but several studies also show the activation of TA systems 
by stressful conditions in other bacteria. For example, in Xylella fastidiosa, the 
MqsRA system is activated upon copper stress (Merfa, et al., 2016). Moreover, 
several TA systems of Salmonella enterica are triggered during exposure to 
erythromycin and tetracycline (Donegan & Cheung, 2009). Therefore, although 
the research on TA systems’ activating conditions in other bacteria has not been 
as systematic as in E. coli, the activation upon different stresses seems to be a 
universal trait. 
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2.2.2. Targets of type II TA systems’ toxins 
The activation of TA systems triggers the toxin proteins. As briefly mentioned 
above, the toxins of type II systems most commonly target translation. Most of 
them inhibit protein synthesis by cutting mRNA, but some also cleave rRNA, 
tRNA or tmRNA (Winther & Gerdes, 2011, Schuessler, et al., 2013, Schifano 
& Woychik, 2014). 
The mechanisms of action also vary within the groups of toxins with a 
similar target. Many toxins that cleave mRNA, e.g. RelE, YafQ, and YoeB of E. 
coli, need to be bound to ribosome to exert their nuclease effect (Pedersen, et 
al., 2003, Christensen-Dalsgaard & Gerdes, 2008, Prysak, et al., 2009, Zhang, 
et al., 2009). Other toxins with the mRNA target, e.g. E. coli HicA and MazF, 
cleave mRNA independent of the ribosome (Zhang, et al., 2003, Jorgensen, et 
al., 2009). The mRNase toxins also differ by their recognition sequence. Some 
of them have short target sequences that occur often in different mRNAs. For 
example, the ribosome-dependent YafQ toxin from E. coli cleaves the AAA 
codons that are followed by G or A nucleotide (Prysak, et al., 2009). The HigB 
toxin from the Rts-1 plasmid also cuts the AAA or ACA codons, whereas an A 
in the third position of the codon ensures an effective cleavage (Hurley & 
Woychik, 2009, Schureck, et al., 2014). The ribosome independent MazF toxin 
from E. coli cleaves mRNAs at ACA sites (Zhang, et al., 2003). These short re-
cognition sites probably explain why these toxins rapidly decompose the 
cellular mRNAs and have a drastic effect on bacterial physiology (Zhang, et al., 
2003). Still, some MazF family toxins recognise much longer sequences. For 
example, MazF homologues from pathogenic species Clostridium difficile, S. 
aureus and Mycobacterium tuberculosis cleave either the five-base sequence 
UACAU (MazF-cd and MazF-Sa) or UUCCU/CUCCU (MazF-mt3), or UCGCU 
(MazF-mt7) and thus target just a specific set of mRNAs (Zhu, et al., 2008, 
Zhu, et al., 2009, Rothenbacher, et al., 2012, Williams & Hergenrother, 2013). 
These sequences have an uneven distribution among cellular RNAs, being 
especially over- (Zhu, et al., 2009, Rothenbacher, et al., 2012) or under-
represented (Zhu, et al., 2008, Williams & Hergenrother, 2013) in pathogenicity 
factors. It has been suggested that these more specific toxins comprise a distinct 
group, which is important in the pathogenicity of bacteria rather than in growth 
regulation (Zhu, et al., 2009). 
In addition to the variable sequence recognition by MazF toxins in different 
bacteria, some of the members of this toxin family do not cleave mRNA. So, 
M. tuberculosis encodes at least nine MazF family toxins (Schifano, et al., 
2013), but rather than targeting mRNA, several of them cleave other types of 
RNA. For example, MazF-mt6 and MazF-mt3 (in addition to mRNA) target 
ribosomal RNA (Schifano, et al., 2013, Schifano & Woychik, 2014, Schifano, 
et al., 2014), and MazF-mt9 cuts tRNA (Schifano, et al., 2016). tRNA is also 
cleaved by a mycobacterial VapC4 toxin (Cruz, et al., 2015), whilst another 
VapC homolog in M. tuberculosis, the VapC20, cleaves 23S ribosomal RNA 
instead (Winther, et al., 2013). Even tmRNA has been shown to be cleaved by a 
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type II toxin, the HigB of M. tuberculosis (Schuessler, et al., 2013). Thus, all 
the types of RNA can be targeted by type II TA toxins. Translation can also be 
inhibited by using other ways as exemplified by the bacteriophage P1-encoded 
Doc and the E. coli HipA toxins, which phosphorylate the translation factor EF-
Tu (Castro-Roa, et al., 2013) and the glutamyl-tRNA-synthetase GltX 
(Germain, et al., 2013, Kaspy, et al., 2013), respectively. The RatA toxin, also 
known as PasT, interferes with translation by binding to the ribosomal 50S 
subunit and inhibiting the assembly of 70S ribosomes (Zhang & Inouye, 2011). 
Although a vast majority of type II toxins inhibit translation, some of them 
affect other major processes. For example, the CcdB and ParE toxins inhibit 
replication by binding the DNA gyrase, an enzyme required to relieve 
supercoiling in front of the replication fork (Cozzarelli, 1980, Yuan, et al., 
2010). The PezT toxin of Streptococcus pneumoniae phosphorylates peptido-
glycan precursors and thereby inhibits cell wall synthesis (Mutschler, et al., 
2010). Summing up, just like type I systems that have mostly membrane-
damaging toxins, but have other targets as well, the type II toxins mostly inhibit 
translation but also have some alternative targets. 
 
 
2.3. Type III TA systems 
Analogously to the type I TA systems, the antidote role of type III TA modules 
is carried out by a small RNA. However, the mechanism of inhibition of a toxin 
is entirely different. The type III antitoxin is an sRNA composed of nucleotide 
direct repeats, which fold into hairpin-like structures and inactivate the toxic 
protein by binding it through RNA-protein interactions (Fig 4). Two TA 
systems belonging to the type III family have been characterized so far: ToxIN 
and AbiQ-antiQ. In both systems, the toxins elicit their poisonous effect through 
ribonucleolytic cleavage and induction of growth arrest, which can be reversed 
by increased production of cognate antitoxins (Blower, et al., 2011, Samson, et 
al., 2013, Short, et al., 2013). 
 
 
Figure 4. Type III TA system. The sRNA antitoxins fold into hairpin like structures, the 
toxic proteins bind the antitoxin RNA, which results in their inactivation. Free toxins 
have ribonucleolytic activity and they inhibit translation. The antitoxin is depicted in 
blue and the toxin in red colour. 
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How the activity of type III TA toxins is triggered has remained ambiguous 
as both the toxins and the antitoxins are continuously expressed throughout the 
growth (Fineran, et al., 2009, Samson, et al., 2013). For the activation of ToxN 
toxin, it has been hypothesized that upon phage infection the toxin:antitoxin 
ratio in the cell is altered due to the suppression of transcription and translation 
or the degradation of the host DNA (Fineran, et al., 2009). For the AbiQ-antiQ 
system, there are no remarkable changes in the levels of the two counterparts 
during phage infection, so it is more likely that the toxin is activated by some 
other mechanism of switching the toxin into an active form which still needs to 
be discovered (Samson, et al., 2013). 
 
2.4. Type IV TA systems 
Type IV group of TA systems is comprised of very unconventional systems 
because the antitoxin does not inhibit the toxin itself but rather counteracts the 
toxin’s effect by stabilizing the target of the toxin (Masuda, et al., 2012) (Fig 5). 
For example, the CbeA antitoxin binds to and promotes bundling of FtsZ and 
MreB filaments and thereby counteracts the CbtA toxin’s effect on the 
inhibition of cytoskeleton (Masuda, et al., 2012). Moreover, the antitoxin CbeA 
has been shown to protect bacteria from other cytoskeleton inhibiting proteins 
as well (Masuda, et al., 2012). Considering that this antitoxin does not 
inactivate solely its toxin, but also other FtsZ or MreB inhibitors like SulA and 
A22 (Masuda, et al., 2012), classification of the type IV module within the TA 
systems can even be considered questionable. As there is no direct interaction 
between the two counterparts, one could count any harmful protein and its 
repressor a TA system. 
 
 
Figure 5. Type IV TA system. The TA proteins do not interact directly; the antitoxin 
counteracts the toxin by stabilizing its target. The antitoxin is blue and the toxin red. 
However, another TA system, AbiE from Lactococcus lactis, has been recently 
described to function through a type IV suppression mechanism as well. Ectopic 
overexpression of AbiEii toxin was shown to be counteracted by its antitoxin 
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AbiEi without complex formation between the two proteins (Dy, et al., 2014). 
The mechanism of action of this system is currently not clear. However, as the 
toxin AbiEii was predicted to belong to a nucleotidyl transferase superfamily 
and it specifically binds GTP, it is proposed that AbiEii inactivates its so far 
unknown target by guanylylation (Dy, et al., 2014). The counteraction of the 
antitoxin AbiEi might be removing the toxin-added GMP (Dy, et al., 2014), but 
this has yet to be experimentally confirmed as well. The regulation of the AbiE 
operon resembles to that of the type II systems, as the transcription of the AbiE 
is autorepressed by the antitoxin. Since the proteins do not interact and the 
AbiEii toxin does not act as an autorepressor, naturally, no conditional 
cooperativity in the regulation can occur (Dy, et al., 2014). 
 
 
2.5. Type V TA system 
Only one type V TA system has been described to date. The system is named 
GhoST as the toxin GhoT interferes with the inner membrane integrity and 
results in lysed cells with damaged membranes (ghost cells) (Wang, et al., 
2012). GhoST system has features similar to type I systems as the membrane 
damaging toxin GhoT is also inhibited by the cognate antitoxin prior to the 
synthesis of the toxin protein. However, the inhibition is achieved by cleavage 
of the GhoT mRNA by proteic GhoS that has endoribonucleolytic activity 
(Wang, et al., 2012) (Fig 6). Differently from other proteinaceous systems, 
GhoS antitoxin is not degraded during stress and neither does it possess a DNA 
binding ability. The regulation of the system instead involves another TA 
system. It has been shown that the activation of the type II MqsRA system 
increases the mRNA ratio of GhoT to GhoS, as the toxin MqsR preferentially 
degrades the mRNA of GhoS antitoxin (Wang, et al., 2013). Hence, upon stress, 
when MqsR is activated, the GhoS mRNA levels drop and the GhoT toxin can 
be produced. 
 
Figure 6. Type V TA system. The protein antitoxin (GhoS) degrades the toxin (GhoT) 
mRNA. The toxic protein damages the bacterial inner membrane. The antitoxin is blue 
and the toxin red. 
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The type I and V toxins are mostly membrane-spanning, pore-forming peptides 
and all of them are inhibited before their synthesis. Therefore, it is tempting to 
speculate that toxins of this nature have to be inhibited before translation 
because once in the membrane, they already exert their toxic effect and are thus 
hard to counteract. 
 
 
2.6. Type VI TA system 
Recently, a new type of TA system has been described in Caulobacter 
crescentus (Aakre, et al., 2013). The type VI SocAB system differs from all 
other TA pairs, as the antitoxin SocA is a destabilizer of the toxin SocB (Fig 7). 
While usually the toxins are stable proteins, SocB is labile and degraded by 
ClpXP protease. SocA antitoxin is required as an adaptor and its binding to the 
toxin is needed for the degradation to occur. In the absence of the antitoxin, the 
toxin is not degraded and replication elongation is inhibited by SocB binding to 
β-sliding clamp and outcompeting other clamp-binding factors (Aakre, et al., 
2013). 
 
Figure 7. Type VI system. The antitoxin (SocA) is a proteolytic adaptor. It binds the 
toxin (SocB) and promotes its degradation. The antitoxin is blue and the toxin red. 
Categorising the TA systems into different groups can be considered a violent 
and artificial approach. Nevertheless, to create more clarity into the diverse 
world of TA systems, it seems to be a reasonable practice. The different 
inactivation ways of toxins may have a meaning in understanding the systems. 
For example, as exemplified by the type I and V systems, in some cases it may 
be better not to allow the toxin to be synthesised at all. On the other hand, the 
advantage of the type II systems is that their activation can be achieved quicker 
as the protein toxin is already present in the cell in a harmless form of a TA 
complex. Thus, no protein production is required for toxin to be able to 
influence the physiology of bacteria. The most recently described TA types 
(IV–VI) broaden the world of TA systems and suggest that many more different 
TA types could possibly exist that still remain to be discovered. 
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3. The abundance and potential cross-talk between 
multiple TA systems 
The genes for TA systems are widespread in the chromosomes of bacteria, 
particularly in the pathogenic and free-living species that encounter many 
different stresses during their life (Pandey & Gerdes, 2005). The chromosomal 
distribution of TA loci in bacteria is well correlated with the diversity of the 
environment they inhabit. So, obligate intracellular parasites that live in stable 
and predictable conditions, harbour only few or none TA systems. For example, 
obligate intracellular parasites such as different Chlamydiacea spp. have no 
chromosomal TA systems (Leplae, et al., 2011). This suggests that in un-
changing, stable conditions the TA systems lose their beneficial effects and 
respective genes are eliminated from the genome. On the contrary, in fluctuating 
environments, they seem to confer an advantage and have thus been maintained 
throughout evolution (Pandey & Gerdes, 2005). For example, a stark contrast 
can be seen in the genus Mycobacteria, where intracellular M. leprae encodes 
only one set of TA genes (Leplae, et al., 2011), whereas M. tuberculosis 
encodes no less than 88 TA systems in its chromosome, of which at least 63 
have been functionally tested in E. coli and/or M. smegmatis with 37 proven 
active under at least one tested condition (Gupta, 2009, Ramage, et al., 2009, 
Huang & He, 2010, Singh, et al., 2010, Zhu, et al., 2010, Ahidjo, et al., 2011, 
Sala, et al., 2014). This indicates both the benefits as well as the costs of the TA 
systems: a high number of functional systems suggests that these TA loci confer 
beneficial effects on M. tuberculosis survival; on the other hand, as many 
mycobacterial TA systems have lost their functionality (Sala, et al., 2014), the 
TA loci seem to be under strong selection. 
The high number of TA modules in one bacterium raises many intriguing 
questions. Firstly, what could be the relationship between the proteins from 
different systems and secondly, if there is regulatory cross-activation between 
the systems? These questions seem particularly relevant when considering that 
47 (about half have been confirmed to have active toxins in M. smegmatis) of 
M. tuberculosis TA systems are of the VapBC type (Ramage, et al., 2009, 
Ahidjo, et al., 2011). One would expect that similar TA proteins of the same 
family could interact with one another. Nevertheless, analysis of four hetero-
logous VapBC toxins and antitoxins showed that the antitoxins could inhibit 
only their cognate toxin (Ramage, et al., 2009, Ahidjo, et al., 2011). Although 
not all the systems were tested, it clearly indicates a high specificity for at least 
the VapBC systems in M. tuberculosis. Several other studies also indicate that 
most TA proteins are very specific to interact with only their cognate partners 
(Masuda, et al., 1993, Fiebig, et al., 2010, Nolle, et al., 2013). Considering that 
maintaining the toxin:antitoxin ratio is crucial for a bacterium, it is 
comprehensible why the proteins of one system do not interact with those of 
other systems. Yet, there are some indications of complex interactions between 
the members of different systems. For example, the three RelBE family systems 
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in M. tuberculosis are able to form heterologous TA complexes where RelB 
antitoxins also neutralize other RelE toxins besides their own partners (Yang, et 
al., 2010). Interaction between the proteins from different systems has also been 
recorded for two M. tuberculosis MazEF (mt1 and mt3) systems. Moreover, the 
proteins of these systems could also interact with proteins of two VapBC 
systems of this bacterium (Zhu, et al., 2010). Yet, the opposite results have been 
obtained by others, as no cross-interaction between three mycobacterial MazEF 
systems (MazEF-mt3, mt6 and mt9) was seen (Tiwari, et al., 2015a). The 
discrepancy between different studies may originate from different experimental 
design. In their TA protein interaction experiments Zhu et al (Zhu, et al., 2010) 
expressed the toxins from arabinose-inducible PBAD promoter and antitoxins 
from an IPTG-inducible Ptac promoter. However, as IPTG directly inhibits the 
PBAD promoter, the experiments by Zhu et al could have given artificial results 
(Kasari, et al., 2013). Thus for truthful results, the promoters being used for the 
expression of TA proteins should be carefully considered or direct interactions 
between the TA proteins confirmed experimentally. 
The regulatory cross-activation between different chromosomal TA systems 
has also been observed. Moreover, this cross-regulation can include members of 
different types of TA systems. In a recently published study, the adjacently 
located type II MazEF system and type I TxpA/ratA of Enterococcus faecalis 
were shown to activate each other (Wessner, et al., 2015). The regulatory 
interplay relied on the ability of the MazEF complex to not only autorepress its 
own transcription, but also to activate the expression of the neighbouring ratA 
gene. The binding of MazEF complex on the ratA promoter decreased the 
amount of MazEF proteins that could otherwise repress the mazEF locus, thus 
leading to the activation of the mazEF transcription as well (Wessner, et al., 
2015). As already mentioned in chapter 2.5, the type II TA system MqsRA 
regulates the type V GhoST system in E. coli (Wang, et al., 2013). The toxin 
MqsR preferentially cleaves the GhoS mRNA, thus decreasing its levels and 
inducing the GhoT toxin’s activation. Cross-activation between other type II TA 
systems in E. coli has also been proposed (Kasari, et al., 2013) and the 
cumulative effect of type II TA systems’ deletions on persister cell formation 
(Maisonneuve, et al., 2011) suggests that different TA systems may constitute a 
coordinately acting regulatory network (see also chapter 4.2.3.). The fact that 
some systems regulate or interact with each other, whereas other systems do 
not, indicates that these systems could have different roles in bacterial 
physiology. Some situations likely require more holistic TA systems’ action, 
whereas others may need a more specific approach by individual TA systems. 
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4. Functions of chromosomal TA systems 
Considering that TA toxins from all types can have many different targets and 
they inhibit vital processes and structures of bacteria, an intriguing question to 
ask is: what could be the benefit of these noxious systems? This question 
became increasingly attractive when aside of plasmids, the TA systems were 
found to be abundant in bacterial chromosomes (Pandey & Gerdes, 2005). 
While the importance of the plasmid-borne TA systems in plasmid stabilization 
is quite straightforward (Fig. 1), the importance of such systems in chromo-
somes is much more difficult to understand. 
The high number of TA loci in bacterial chromosomes (Pandey & Gerdes, 
2005) suggests that they play important role(s) in the life of bacteria. Although 
some TA systems are inactive and probably just remnants of mobile genetic 
elements (Mine, et al., 2009, Ramage, et al., 2009), others seem to be very 
important for bacteria. Throughout the years of the TA studies, there has been 
much debate about the functions of the chromosomal TA systems. The roles 
proposed for genomic TA modules include maintenance of genetic islands, 
protection against bacteriophages and increasing amount of data suggest that 
they play an important role in bacterial stress management (Unoson & Wagner, 
2008, Wang, et al., 2011). All these options are discussed more thoroughly in 
the next few chapters. 
 
 
4.1. Protection from DNA loss 
TA modules can be often found in the mobile parts of the chromosomes such as 
superintegrons (Rowe-Magnus, et al., 2003) or pathogenicity islands (Ma, et al., 
2013). In resemblance to the plasmid-borne TA systems that contribute to the 
maintenance of plasmids, several chromosomal TA pairs can also hinder large-
scale deletions of otherwise disposable genomic regions. Vibrio cholerae, a 
bacterium that has two chromosomes (Heidelberg, et al., 2000), portrays a good 
example for such a role of chromosomal TA pairs. The larger chromosome 
(chr I) encodes most of the vital genes, whereas the second one (chr II) is smaller 
and has only very few essential genes. On the other hand, 17 out of the 18 TA 
systems of V. cholera are encoded on chr II, within one superintegron (Iqbal, et 
al., 2015). It has been shown that ParDE modules of V. cholerae control the 
missegregation of chr II and thus, contribute to its stabilization. Upon the loss of 
the smaller chromosome, the toxins are liberated from the antitoxin-mediated 
control and degrade the essential chr I, thereby killing the cell (Yuan, et al., 
2011). The MosAT system of V. cholerae has also been shown to have a similar 
function in maintaining an integrative and conjugative element SXT (Wozniak 
& Waldor, 2009). In order to undergo conjugation, the element has to be 
excised from the chromosome and circulate. Yet, under these conditions the 
MosAT system, encoded on the element, is activated and prevents the loss of 
SXT, probably by PSK mechanism (Wozniak & Waldor, 2009). The mechanism 
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of action of MosT is still not clear and the possibility of MosT acting prior to 
the loss of the SXT cannot be ruled out either. In that case, MosT would inhibit 
the growth of bacteria to increase the possibility of reintegrating the SXT 
element into the chromosome (Wozniak & Waldor, 2009). While these few 
examples illustrate the chromosomal TA systems acting similar to the plasmidic 
ones, most of the chromosomal systems have other functions. 
 
 
4.2. TA systems in stress management 
Increasing amount of data associates TA modules with survival under stress. 
The involvement of TA systems in stress response is suggested by the high 
number of systems that are activated in stressful conditions (chapter 2.2.1.3). 
Additionally, many TA systems are integrated into global stress-response 
pathways, e.g. SOS-response induces YafQ-DinJ, YafON and TisB-IstR systems 
(Vogel, et al., 2004, Prysak, et al., 2009, Singletary, et al., 2009, Dörr, et al., 
2010); a number of TA systems are activated by the stringent response, induced 
by (p)ppGpp (Germain, et al., 2015). The antitoxin MqsA can even regulate the 
RpoS-controlled general stress response in E. coli as it directly represses the 
expression of the rpoS gene (Wang, et al., 2011). So the production of the 
stress-specific sigma factor is increased upon oxidative stress, when the amount 
of MqsA decreases (Wang, et al., 2011, Wang & Wood, 2011) (chapter 2.2.1.2).  
Below, I give a short overview on TA systems functioning in: (i) protection 
against bacteriophages; (ii) biofilm production; (iii) regulation of growth and 
dormancy; and (iv) survival in the host organism upon infection. 
 
 
4.2.1. Protection against bacteriophages 
As in case of humans who are stressed when they become ill, the attack by 
bacteriophages inflicts a great stress to bacteria and can trigger various stress 
responses. Recent findings suggest that several chromosomal TA systems play an 
important role in protecting bacterial host from phage infection (Hazan & Engel-
berg-Kulka, 2004, Fineran, et al., 2009, Samson, et al., 2013). Phage invasion 
causes stress leading to increased degradation of antitoxins and consecutive 
activation of toxins. For example, RnlAB system from E. coli, is considered to 
be a phage-defence module: phage infection triggers the degradation of the 
antitoxin RnlB and the activation of the RnlA toxin resulting in phage mRNA 
degradation and the blocking of the expression of phage genes (Koga, et al., 
2011). A bacteriostatic effect upon phage invasion has also been observed for 
the type III ToxIN and type IV AbiE systems, where phage invasion triggers 
toxin activation and reversible inhibition of growth, which is restored after the 
stress has passed (Fineran, et al., 2009, Dy, et al., 2014). 
The other strategy of protecting bacterial population from spread of phages 
is much more severe and involves death of phage-infected bacteria. This kind of 
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phage defence has been reported for E. coli MazEF system, which is the first 
chromosomal TA system to be confirmed to have a function in protection against 
phages. The MazEF is among the most studied TA systems and represents a 
chromosomal module that has been suggested to trigger programmed cell death 
(PCD) of bacteria (Sat, et al., 2001, Engelberg-Kulka, et al., 2005). As proposed, 
the MazEF-mediated PCD functions as a defence mechanism of a bacterial 
culture against P1 phage spread (Hazan & Engelberg-Kulka, 2004). Dying of 
individual cells has been considered as an altruistic mechanism to improve the 
survival of the remaining population (Hazan & Engelberg-Kulka, 2004). 
However, the PCD mechanism of MazEF system in phage defence has been 
questioned by various researchers (Pedersen, et al., 2002, Yamaguchi & Inouye, 
2011, Ramisetty, et al., 2016). Indeed, PCD induced by the MazEF system has 
only been shown by one research group for one certain E. coli strain MC4100, 
which is reported to be relA+ (Hazan, et al., 2001, Sat, et al., 2001, Hazan & 
Engelberg-Kulka, 2004, Hazan, et al., 2004, Kolodkin-Gal & Engelberg-Kulka, 
2006). However, this strain actually has a mutation in the relA gene (Tsilibaris, 
et al., 2007) and, moreover, its ΔmazEF derivative additionally has a partial 
deletion of mazG gene, making the wild-type strain relA– and the ΔmazEF 
derivative relA–mazEFG– (Tsilibaris, et al., 2007). For other E. coli strains, 
including MG1655, MC1000 and MC4100 relA+, the PCD mechanism seems to 
not occur (Christensen, et al., 2003, Tsilibaris, et al., 2007). Moreover, even for 
the very same E. coli strain used by the Engelberg-Kulka research group who 
obtained the MazF-mediated PCD results, other researchers could not obtain the 
results to confirm the mechanism (Ramisetty, et al., 2016). 
Still, the MazEF system protects against phage attack. This is also supported 
by the interactions between the chromosomal TA system and phages. Specifi-
cally, the MazEF system suppresses the growth of the T4 phage (Alawneh, et 
al., 2016). Interestingly, T4 has a special way of escaping the anti-phage effects 
of the MazF toxin. It encodes three ADP-ribosyltransferases, and one of them, 
Alt, modifies MazF to decrease its toxicity and inactivate it upon phage infec-
tion (Alawneh, et al., 2016). The T4 phage also encodes a Dmd protein that acts 
as an antitoxin against the RnlA toxin from the RnlAB system of E. coli K-12. 
The Dmd antitoxin enables the phage to escape the anti-phage activity of 
RnlAB (Naka, et al., 2014). Moreover, the phage-encoded antitoxin can also 
inactivate the toxin LsoA from the LsoAB system encoded by a plasmid (Naka, 
et al., 2014). This indicates that TA proteins are used as tools in the evo-
lutionary race between bacteria and phages. 
 
 
4.2.2. Production of biofilm 
Biofilm production is of great importance for bacteria to tackle different stress 
conditions. For example, pathogenic bacteria constantly face stressful conditions 
created by the host organism or antibacterial treatments. Biofilm can protect 
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bacteria against these threats. The TA systems are activated in biofilms, and not 
only in clinical strains (Mitchell, et al., 2010, Hemati, et al., 2014), but also in 
non-pathogenic bacteria (Ren, et al., 2004). Although the deletion of one TA 
locus usually has no major effect on biofilm formation (Lemos, et al., 2005), the 
successive deletion of five TA modules from E. coli strongly influenced biofilm 
formation so that it was decreased at 8 hours of growth, yet, increased after 24 h 
due to the reduced dispersal (Kim, et al., 2009). In V. cholera three of the six 
active relBE loci were reported to contribute to biofilm formation. Two of them 
increased biofilm production and one contributed to its maturation (Wang, et 
al., 2015). 
It has been proposed that TA systems could constitute a switch from plank-
tonic growth to biofilm formation upon stress (Wang & Wood, 2011). However, 
different TA modules influence biofilm formation in different ways (Hu, et al., 
2010). Some of the TA systems in E. coli (MazEF, RelBE, ChpB, YefM/YoeB, 
DinJ/YafQ, MqsRA) control biofilm formation through influencing the 
expression of curli or fimbriae (Kim, et al., 2009, Soo & Wood, 2013), whereas 
the HipA toxin positively influenced biofilm formation by promoting cell lysis 
and increasing the amount of extracellular DNA (Zhao, et al., 2013). The effect 
of MazF and YafQ on biofilm formation has also been shown to be linked to 
their ability to kill cells, yet their involvement is probably not connected with 
the release of DNA (Kolodkin-Gal, et al., 2009). Thus, many TA systems play a 
role in biofilm development, but the mechanisms employed by different systems 
seem to vary widely. 
 
 
4.2.3. Growth regulation and persister cell formation 
Given that toxins target essential cellular processes and structures the general 
outcome of the TA system activation is the slowdown of growth (Schuessler, et 
al., 2013). Importantly, decreasing growth rate is a common strategy to increase 
stress tolerance (Tuomanen, et al., 1986, Eng, et al., 1991). Therefore, it is not 
surprizing that the TA systems-caused growth cessation contributes to the 
tolerance of a wide variety of stresses including exposure to antibiotics (Keren, 
et al., 2004), heavy metals (Harrison, et al., 2005), oxidative stress (Wu, et al., 
2011, Frampton, et al., 2012), UV irradiation (Wu, et al., 2011) and high tem-
peratures (Maezato, et al., 2011, Wu, et al., 2011, Frampton, et al., 2012). The 
growth rate inhibition can be quite strong and in many cases, the toxins are so 
severe that the cell growth is ceased entirely (Pedersen, et al., 2002). 
The toxin-mediated growth cessation has been associated with the formation 
of metabolically inactive and dormant persister cells. Multi-drug tolerant 
persister cells of clinical isolates pose a high risk in medicine as persister 
formation is considered a major reason of relapsing infections after antibiotic 
treatment (Conlon, 2014). To tackle the problem of persistent bacteria, the 
molecular mechanisms of their emergence and the involvement of TA systems 
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in persistence have been studied extensively (Lewis, 2010, Maisonneuve & 
Gerdes, 2014, Page & Peti, 2016). It has frequently been shown that the effect 
of any particular TA module on persistence is minor: the deletion of a single 
system usually has no effect on the number of dormant cells (Maisonneuve, et 
al., 2011). However, bacteria usually possess multiple TA systems and for 
example in E. coli a combined deletion of at least five TA systems decreased 
the number of persisters significantly, whereas the deletion of 10 TA loci 
decreased the amount of persisters by more than two orders of magnitude 
(Maisonneuve, et al., 2011). Yet, persister formation between bacterial species 
differ. In Salmonella Typhimurium the deletion of each single TA module 
already decreased persister formation (Helaine, et al., 2014). Moreover, it has 
been shown that three RelE homologues in M. tuberculosis induce growth 
stasis, but rather than contributing to overall persistence, each toxin increases 
the tolerance to distinct antibiotics (Singh, et al., 2010). 
The persistence induced by TA toxins is a subpopulation phenotype, 
meaning that only a small number of cells in the population become persisters. 
In E. coli, persister formation is shown to originate from the activation of TA 
systems in response to stochastic increase of (p)ppGpp concentration (Maison-
neuve, et al., 2013). The synthesis of this stringent response alarmone is usually 
induced by nutritional stress [(Chatterji & Ojha, 2001), see also chapter 
2.2.1.3.]. Yet, (p)ppGpp levels can occasionally rise above a certain threshold in 
sporadic cells also in nutrient-rich conditions, as has been recently shown by 
Maisonneuve and colleagues (Maisonneuve, et al., 2013). Moreover, one of E. 
coli TA toxins can enhance the (p)ppGpp production and persister cell 
formation. The active toxin HipA phosphorylates the glutamyl-tRNA synthetase 
GltX (Germain, et al., 2013) that leads to accumulation of uncharged tRNAGlu 
and stalls ribosomes, which in turn activates the RelA-dependent production of 
(p)ppGpp (Germain, et al., 2015) (Fig 8). In the cells with increased alarmone 
molecule levels, the cellular proteases Lon and Clp are activated, TA antitoxins 
are degraded, and the liberated toxins will suppress cell growth and induce 
persistence (Maisonneuve, et al., 2013) (Fig 8). An analogous (p)ppGpp-
dependent activation pathway has also been suggested for the type I hokB-sokB 
system (Verstraeten, et al., 2015). Thus, a well-ordered regulatory pathway for 
the activation of different TA systems has been proposed in E. coli (Germain, et 
al., 2015, Verstraeten, et al., 2015). 
Yet, the results of the T. K. Wood group reveal that the (p)ppGpp-dependent 
pathway cannot explain all aspects of persister formation in E. coli as TA-
mediated persistence also occurs in the absence of (p)ppGpp (Chowdhury, et 
al., 2016). Moreover, what is true for E. coli is not necessarily true for all other 
bacteria. For example, (p)ppGpp-mediated stringent response and TA modules 
do not control persister formation in S. aureus (Conlon, et al., 2016). The 
regulation of persister cell formation in S. aureus rather involves decreased 
levels of ATP, which leads to the expression of stationary-phase markers, genes 
arcA and cap5A, and induces dormancy (Conlon, et al., 2016). Nevertheless, in 
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clinical strains of M. tuberculosis numerous TA systems are upregulated in 
mutants with high persister frequency (Torrey, et al., 2016) and most 
characterized TA toxins can cause reversible growth arrest and dormancy 
(Pedersen, et al., 2002, Schmidt, et al., 2007, Kasari, et al., 2010). Thus, the 
majority of TA systems in various bacterial species are involved in growth 
regulation and persistence, but possibly in a different manner than described for 
E. coli. 
 
 
Figure 8. The (p)ppGpp-dependent pathway of induction of persister formation in 
E. coli. Active HipA toxin phosphorylates GltX, which leads to the accumulation of 
uncharged tRNAGlu that stalls ribosomes. This triggers RelA-dependent (p)ppGpp 
synthesis. Increased levels of (p)ppGpp inhibit PolyP phosphatase PPX, which leads to 
accumulation of PolyP produced by polyphosphate kinase PPK. As a result, Lon 
protease is activated, TA antitoxins degraded and the TA toxins (including HipA) 
activated. The mRNAse activity of toxins finally leads to induction of persistence 
[adapted from (Germain, et al., 2015)]. 
 
4.2.4. Contributors to virulence 
Previously described functions of TA systems in biofilm and persister cell 
formation were shown to be beneficial for pathogenic bacteria as they help to 
survive under different stresses the bacteria encounter upon infecting their host 
organism (Stallings & Glickman, 2010, Wang, et al., 2015). The importance of 
TA systems in virulence was first suggested by their great prevalence in 
infectious bacteria, but there are also many experimental evidences to support 
their requirement for pathogenic microbes. For instance, the TA systems-caused 
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persistence and biofilm formation help pathogenic species to overcome both 
immune responses as well as antibiotic treatments (Ceri, et al., 1999, 
Kedzierska & Hayes, 2016). In uropathogenic strains of E. coli and pathogenic 
Haemophilus influenzae they promote survival and also colonization ability in 
animal organs (Norton & Mulvey, 2012, Ren, et al., 2012, Ren, et al., 2014). 
The same effect has been observed for E. faecalis, where the deletion of the 
antitoxin of the Fst toxin caused hypervirulence and improved colonization 
ability of the mutant compared to the wild-type bacteria (Michaux, et al., 2014). 
Also, deleting three MazF-mt genes from the M. tuberculosis chromosome 
decreased its ability to colonize and damage infected tissues (Tiwari, et al., 
2015b, Tiwari, et al., 2015a). The MazF-mt systems increase the tolerance of 
bacteria to different stress conditions that can occur during infection and 
contribute to the survival in macrophages (Tiwari, et al., 2015a). The triple-
deletion of MazF-mt toxins decreases persister cell formation (Tiwari, et al., 
2015a), so the influence on virulence by these systems can probably be 
attributed to increased level of persisters. The association of TA modules with 
virulence has also been observed for the cholera pathogen V. cholerae. Two 
RelBE systems in this bacterium contribute to colonization both in vitro and in 
vivo mice models, although the mechanism of action of these systems is not 
clear (Wang, et al., 2015). They affect neither the tolerance of V. cholerae to 
bile or reactive oxygen species, which are frequently encountered by bacteria 
upon infection, nor does their deletion change the expression of virulence 
factors (Wang, et al., 2015). TA systems are also widespread and actively 
transcribed in clinical isolates of Pseudomonas aeruginosa (Williams, et al., 
2011), S. aureus (Williams, et al., 2011), Enterococcus faecium and E. faecalis 
(Komi, et al., 2015), although the involvement of the systems in the virulence of 
these bacteria remains a subject of future research. 
Increasing data support the involvement of TA systems in virulence, whereas 
the ways how TA systems influence pathogenicity are complex and diverse (De 
la Cruz, et al., 2013) and for many systems the exact mechanism has not been 
confirmed yet. Nevertheless, the main strategy of TA toxins in supporting the 
virulence is probably to promote the stress tolerance of a pathogen by 
increasing the number of persistent cells in a population. 
 
 
5. TA systems in Pseudomonas spp. 
TA systems are most thoroughly studied in E. coli, but also in species of 
Staphylococcus (Bukowski, et al., 2013, Nolle, et al., 2013, Williams & 
Hergenrother, 2013, Schuster, et al., 2015), Bacillus (Silvaggi, et al., 2005, Fico 
& Mahillon, 2006, Wu, et al., 2011, Jahn, et al., 2012), Salmonella (De la Cruz, 
et al., 2013, Helaine, et al., 2014) and Mycobacterium (Singh, et al., 2010, 
Frampton, et al., 2012, Tiwari, et al., 2015a). Interestingly, at the time I started 
my PhD studies, hardly any data about TA systems in pseudomonads were 
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available, although the members of this genus have been of great interest to 
numerous researchers. P. aeruginosa is the most studied species in this genus 
due to its pathogenicity to human. On the other hand, research on P. putida is 
mostly instigated by its remarkable metabolic capabilities that allow a high 
tolerance to different stresses and potential use in bioremediation (Belda, et al., 
2016). All in all, the genus Pseudomonas inhabits a large variety of environ-
ments and includes plant growth promoting soil bacteria (P. putida, P. fluo-
rescens) as well as plant pathogens (P. syringae) and human pathogens 
(P. aeruginosa). Yet, when I started my PhD studies, there were only some 
bioinformatic predictions about the distribution of TA systems in these bacteria 
(Pandey & Gerdes, 2005, Makarova, et al., 2009, Shao, et al., 2011), and just 
one study that confirmed active transcription of three TA systems in clinical 
isolates of P. aeruginosa (Williams, et al., 2011). No confirmation about TA 
systems’ functionality in this genus had been published. 
The unsteady environments inhabited by Pseudomonas species (Silby, et al., 
2011) suggest the importance of TA systems in this genus. Indeed, for each 
fully sequenced Pseudomonas strain, at least a few TA systems have been 
predicted. The number of the systems varies from only four in P. aeruginosa 
PAO1 to 19 in P. syringae pv. tomato DC3000 (Makarova, et al., 2009, Shao, et 
al., 2011). Given that TA genes are small and not easily recognized, it is not 
surprising that the number of TA systems for each species varies in different 
predictions. For example, for P. putida KT2440, the pet bacterium of our 
laboratory, the results vary from 8 (Pandey & Gerdes, 2005) to 12 (Makarova, 
et al., 2009) and 15 (Shao, et al., 2011). One recent study showed that in 
P. putida, the number of different TA systems is higher for the environmental 
than for clinical strains (Molina, et al., 2016), whereas the TA systems can be 
grouped into environmental, clinical, and universal clusters (Molina, et al., 
2016). This suggests that certain TA systems may play distinct roles in bacterial 
physiology at specific situations, although the experimental data on this subject 
is yet scarce. Still, the number of type II TA modules in pseudomonads has 
been found to be positively correlated with the persistence to antibiotics as more 
persistent Pseudomonas species possessed more type II TA systems in their 
chromosomes (Vogwill, et al., 2016). 
During the four years of my studies, the research about these fascinating 
systems has advanced and some functional studies of TA systems in pseudo-
monads have been published by now. For example, the functional analysis of 
the HicAB system of P. aeruginosa showed that the overexpression of the HicA 
toxin in E. coli suppresses growth and causes cell aggregation. Yet, the deletion 
of the entire hicAB locus from P. aeruginosa had no effect neither on biofilm 
formation nor virulence in mice (Li, et al., 2016). The result is actually not 
surprising considering that single TA deletion mutants mostly show no re-
cognizable phenotype (Maisonneuve, et al., 2011). 
Another TA system with assayed functionality is HigBA system of 
P. aeruginosa. The authors demonstrated that the HigB of P. aeruginosa has an 
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mRNase activity just like previously described toxins from this family (Hurley 
& Woychik, 2009), yet, differently from the HigBA system of V. cholerae 
(Budde, et al., 2007), the antitoxin gene higA could be disrupted in the chromo-
some of P. aeruginosa (Wood & Wood, 2016), which suggests a more moderate 
toxicity for the HigB toxin. Surprisingly, the experiments with a transposon 
mutant of higA antitoxin of P. aeruginosa PA14 indicate that the HigB toxin 
has a negative effect on biofilm formation (Wood & Wood, 2016). Moreover, 
the levels of virulence factors pyochelin and pyocyanin were reduced at least 
two-fold in the antitoxin knockout strain (Wood & Wood, 2016). This indicates 
that TA systems may act very differently in the genus Pseudomonas compared 
to other bacteria as most TA toxins have been shown to increase virulence and 
biofilm production (see chapters 4.2.2. and 4.2.4.). Data on HigBA system in 
P. aeruginosa suggests an entirely opposite effects: the toxin proposedly 
decreases virulence of bacteria. However, as the cited work (Wood & Wood, 
2016), did not include measurement of virulence itself, no clear conclusions can 
be made about the effects of the HigBA on regulation of pathogenicity in 
P. aeruginosa. 
Mostly, the studies published on TA systems of Pseudomonas spp. have 
focused only on the phenotypic effects and the mechanisms of respective toxins 
were not addressed. In P. putida KT2440 only one thorough analysis of the 
mechanism of a toxin is on the MazEF-pp system. This work revealed that 
similarly to well-studied E. coli MazEF system, the toxin MazF-pp is an 
mRNAase, which recognises the sequence UAC (instead of ACA of E. coli) 
(Miyamoto, et al., 2016). Yet, as for this system no physiological data are 
available, no final conclusions can be made about its importance to P. putida. 
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THE AIM OF THE THESIS 
This work was initiated by a finding that a transpositional interruption of a 
putative antitoxin gene PP1585 suppressed the glucose-specific lysis of P. putida 
PaW85 deficient in the ColRS signal transduction system (Putrinš, et al., 2011). 
Given that the colR-deficient bacteria have problems with maintaining memb-
rane integrity (Kivistik, et al., 2006, Putrinš, et al., 2008, Putrinš, et al., 2010), 
the antitoxin inactivation probably alleviated the membrane stress. This seemed 
highly intriguing because inactivation of the PP1585, which is the second gene 
in a putative TA system of the PP1586-PP1585 operon, should result in the 
activation of the toxin PP1586. The ability to disrupt the antitoxin gene is in 
itself quite uncommon among TA systems, as it normally leads to toxin-
mediated growth inability. Yet, in the case of PP1586-PP1585, it was not only 
possible to disrupt the antitoxin gene without significant growth impairment, 
but the antitoxin inactivation was even beneficial for the colR-deficient strain 
(Putrinš, et al., 2011). This observation can have two possible explanations. 
Firstly, assuming that the PP1586-encoded toxin is inactive, the stress relief 
could result from antitoxin absence. Bearing in mind that many antitoxins are 
transcription factors, it is possible that PP1585 is a regulator of some unknown 
stress factor. Secondly, PP1586-PP1585 could be a bona fide TA system and 
the disruption of the antitoxin could result in toxin activation and relieve the 
stress the colR– strain experiences. This possibility would suggest an 
uncommonly mild toxicity of the toxin as growth rate of bacteria was only 
slightly reduced after the disruption of the antitoxin gene. Based on these 
intriguing possibilities we hypothesised that: 
• the genes PP1585 and PP1586 encode an active TA system 
• PP1586 codes for an unusually mild toxin able to contribute to the stress 
tolerance of P. putida. 
To control these hypotheses, the functionality and regulation of PP1586-PP1585 
operon-encoded TA system was analysed. 
  
37 
RESULTS AND DISCUSSION 
1. PP1586-PP1585 codes for a functional TA system 
widespread in pseudomonads (Ref I) 
The disruption of an antitoxin gene of a TA system is often impossible (Shah, et 
al., 2006, Budde, et al., 2007) as it results in uncontrolled activation of the toxin 
and growth inhibition. Considering that the transposon-disrupted PP1585 was 
only predicted to be an antitoxin gene, my first goal was to confirm that the 
PP1586-PP1585 two-gene operon codes for a functional TA system. 
 
 
1.1. The HigBA-resembling PP1586-PP1585 module is widespread 
in the genomes of Pseudomonas spp. 
To get the first insight into the newly discovered system, I started my studies 
with a bioinformatic analysis of PP1586-PP1585 genes. Using the NCBI BLAST 
tool, I searched for putative PP1586-PP1585 homologs in the chromosomes of 
other bacteria and found that the most similar protein to PP1585 was a predicted 
HigA family antitoxin from Nitrosococcus halophilus Nc4 (57% identity), and 
the most similar protein to PP1586 was a putative killer protein from Delftia sp. 
Cs1–4 (71% identity). The closest chromosome-encoded proteins that had 
already been experimentally described were also proteins of the HigBA system: 
a chromosomal TA system from V. cholerae (identity 37% between PP1586 and 
the HigB toxin and 36% between PP1585 and the HigA antitoxin) and a TA 
system from the Rts-1 plasmid of P. vulgaris (identities 23% and 26% for 
toxins and antitoxins, respectively). Figure 9 shows the alignment of these three 
proteins created by ClustalW2 (Thompson, et al., 1994). 
The structure of the PP1586-PP1585 locus differs from the majority of type 
II TA systems by the arrangement of the two genes. Usually the longer antitoxin 
gene precedes the toxin gene, but in case of PP1586-1585, the order and sizes of 
the partner genes is reversed as is typical also for higBA loci (Ref I, Fig 1A). 
Thus, both the sequence similarity and gene arrangement suggest that the locus 
PP1586-1585 does code for a HigBA family TA system, although the sequence 
identity of PP1586-1585-encoded proteins with previously studied HigBA 
proteins is quite modest (Fig 9).  
To get insight into the system’s distribution, the fully sequenced species of 
the genus Pseudomonas were scanned for orthologues of PP1586-PP1585 genes. 
It turned out that the system is quite conserved in the strains of the variable 
genus Pseudomonas with 30 out of 48 completely sequenced pseudomonads 
containing a TA pair orthologous to PP1586-PP1585 (Ref I, Table 2S). The 
most similar proteins were encoded in the chromosomes of other P. putida 
species, F1 and NBRC 14164, with identities over 97% and 92% for the toxin 
and 99% and 97% for the antitoxin. Besides P. putida strains, the locus is also 
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present in two P. fluorescens strains and one P. stutzeri, P. syringae and 
P. denitrificans strain. Moreover, the locus was found to be present and 
extremely conserved (identity in case of the toxins over 96% and in case of the 
antitoxins over 97%) in all of the 13 fully sequenced P. aeruginosa strains. 
Identity of these orthologues to PP1586 and PP1585 was about 68–70% and 
48–56%, respectively (Ref I, Table 2S). The high conservation of the system 
reflects its possible physiological importance for these bacteria. Considering 
that the orthologues of PP1586-PP1585 were present in all 42 P. aeruginosa 
clinical isolates obtained from 20 cystic fibrosis patients and were actively 
transcribed in all tested strains (Williams, et al., 2011), the system could be 
involved in the virulence of this opportunistic pathogen. 
 
 
 
Figure 9. Alignment of PP1586 and PP1585 proteins with chromosomal (from V. 
cholerae) and plasmid-borne (from Rts1 of P. vulgaris) HigBA. A: PP1586 and HigB 
(toxins), B: PP1585 and HigA (antitoxins). 
* indicates fully conserved residues 
: indicates residues belonging to the same ‘strong’ group 
. indicates residues belonging to the same ‘weak’ group 
The arrow indicates the position of the point mutation E80G in the PP1586 toxin 
 
 
1.2. The PP1586-PP1585 codes for a growth-rate-affecting  
TA system GraTA 
To analyse the functionality of the PP1585-PP1586 system, we deleted the 
genes from the wild-type P. putida PaW85 chromosome individually (antitoxin 
PP1585 – ΔgraA or toxin PP1586 – ΔgraT) as well as knocked out the entire 
operon (PP158-PP1585 – ΔgraTA) (Ref I, Fig 1A). To find out whether the 
previously described lysis suppression of the colR– mutant was either due to the 
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loss of the antitoxin or the activation of the toxin, we constructed respective 
deletion mutants also in the colR-defective strain. By accidental PCR error, we 
obtained an antitoxin deletion mutant with a point-mutation in the toxin gene, 
resulting in replacement of glutamic acid with glycine at the 80th position 
(ΔgraAT(E80G)) (Ref I, Fig 1A). This deletion strain was also included in the 
experiments to investigate the effect of the mutation on the toxin. 
To evaluate the influence of the PP1585-PP1586 genes on the cell envelope 
stress phenotype of the colR-deficient strain, I compared the colR– strain with its 
TA-deletion derivatives using flow cytometry that enables to study the bacterial 
populations at single cell level. The staining of the cells with two DNA-binding 
stains, Syto 9 and propidium iodide (PI), differentiates subpopulations of intact, 
damaged and dead cells. We found that the subgroup of dead cells disappeared 
from the population of colR-deficient bacteria where only the PP1585 gene (the 
antitoxin) had been deleted, yet the deletion of the entire locus showed no effect 
(Ref I, Fig 5A). Therefore, this analysis confirmed that the stress-relieving 
factor was not the PP1585 disruption itself, but rather the presence of PP1586 in 
the absence of PP1585. This strongly suggested that PP1586 codes for a 
functional toxin, which has a stress-relieving effect. Considering that the 
deletion of the antitoxin gene also resulted in a slight growth rate reduction (Ref 
I, Fig 1B), the PP1586-PP1585-encoded TA system was named GraTA for the 
toxin’s growth-rate-affecting ability. 
The fact that antitoxin deletion allowed the cells to grow quite well neces-
sitated a confirmation of the toxin’s activity. Thus, I overexpressed the toxin in 
the wild-type P. putida and its deletion derivatives of the graTA system (ΔgraA, 
ΔgraT, and ΔgraTA) (Ref I, Fig 1A). The ectopic overexpression of GraT 
confirmed its toxicity as it resulted in severe growth defects of bacteria lacking 
the GraA antitoxin (Ref I, Fig 2A). Surprisingly, no apparent effect on growth 
was observed in wild-type bacteria (Ref I, Fig 2A). Thus, the innate antitoxin 
should very efficiently inactivate the overexpressed toxin. To finally confirm 
the counteracting ability of the antitoxin, I overexpressed the GraA antitoxin in 
the same mutants. As the ectopically expressed antitoxin could relieve the 
growth rate reduction caused by the innate toxin (Ref I, Fig 2B), we concluded 
that the graTA codes for a functional TA system. 
The toxin GraT is easily inactivated by the antitoxin GraA. Furthermore, 
even in the absence of the antitoxin, the GraT showed only a moderate effect on 
growth rate of bacteria in optimal conditions (rich broth, 30 °C) (Ref I, Fig 1B). 
Yet, observing these results, one has to bear in mind that usually the effects of 
toxins are studied in overexpression conditions (Gotfredsen & Gerdes, 1998, 
Zhang, et al., 2003, Christensen-Dalsgaard, et al., 2010, Li, et al., 2016), which 
can be quite different from natural ones. Considering that several other chromo-
somal antitoxins can be disrupted without severe effects on bacterial growth, 
similarly to GraTA system (Jorgensen, et al., 2009, Daimon, et al., 2015), it is 
tempting to hypothesize that the toxins expressed from a single chromosomal 
gene copy would not be so noxious as usually presumed from the over-
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expression experiments. Therefore, I would like to emphasize that all the effects 
of the GraT toxin presented in the current thesis are observed in the antitoxin 
deletion strain, which represents the maximum effect that the toxin can have for 
the bacterium in natural situations. 
To find out if the effects of GraT on bacterial growth could be more severe 
in some other growth situations, we tested deletion mutants in non-optimal 
conditions, including various minimal media with different carbon sources and 
at lower (20 and 25 °C) and higher (37 °C) temperatures. These experiments 
revealed that the effect of GraT on growth rate is much more pronounced at 
temperatures below the optimal and the defect of growth disappeared at 37 
degrees (Ref I, Fig 1B), which shows a temperature dependency of the GraT’s 
toxicity. 
The GraTA system most closely resembles the HigBA of the type II TA 
systems. These systems consist of two proteins that interact directly to form a 
complex in which the toxin is inactive (Review of literature, chapter 2.2). To 
test if GraTA shares these features, we co-purified His-tagged GraT with 
untagged GraA. The co-purification resulted in approximately equal amounts of 
both proteins, which shows that a ratio of GraT and GraA proteins in the 
complex is 1:1 (Ref I, Fig 3). In collaboration with R. Loris group, the crystal 
structure of the GraTA complex was recently solved proving that the proteins 
form a tetrameric complex of a GraA dimer and two GraT monomers (Fig 10). 
Interestingly, despite the modest similarity on the sequence level, the structures 
of GraT and GraA proteins are structurally very similar to HigBA proteins from 
the P. vulgaris plasmid-borne system (Schureck, et al., 2014).  
 
 
Fgure 10. Crystal structure of GraTA complex. The GraTA complex consists of a GraA 
dimer bound to two GraT monomers. GraT molecules are blue, one GraA monomer is 
brown and the other one light purple. Amino-acids 23 (N23) to 92 (C) of GraT and 1 (N) 
to 99 (C) of GraA can be seen in the structure (Talavera, Tamman et al., unpublished). 
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Taken together, the first few experiments with graT and graA deletion strains as 
well as the overexpression of GraT and GraA in P. putida verified that GraTA 
is a functional TA system. However, it has many uncommon traits: (i) the toxic 
effect of GraT is probably much milder compared to most TA toxins as it 
allows disruption of the antitoxin gene; (ii) GraT toxin causes a cold-sensitive 
growth inhibition, which has not been described for other type II TA toxins; (iii) 
the innate GraA antitoxin is expected to be a very efficient antidote for GraT as 
the overexpression of the toxin has no observable effects on wild-type P. putida. 
 
 
2. Regulation of the GraTA system (Refs I and II) 
Antitoxins of type II TA systems are usually very labile proteins (Brzozowska 
& Zielenkiewicz, 2013) and need constant production to inhibit the toxin 
(Review of literature, chapter 2.2.1.). To address the unexpected result of the 
uncommon efficiency of GraA to inactivate the overexpressed GraT, it was 
important to understand the regulation of the system. The high efficacy of GraA 
could be achieved by two possible ways: (i) efficient synthesis of the antitoxin 
could guarantee its excess amount over the toxin, (ii) a high stability of the 
antitoxin could ensure efficient inhibition of the ectopically expressed toxin. 
 
 
2.1. graTA is repressed by GraA and derepressed by GraT 
Transcriptional regulation of type II TA systems is usually achieved by auto-
repression of the operon by the antitoxin and/or the TA complex (Loris & 
Garcia-Pino, 2014). TA complex has generally a higher affinity to promoter 
DNA than the antitoxin alone and derepression happens only when the amount 
of toxin exceeds that of the antitoxin. Thus, the expression of a TA operon is 
typically controlled by conditional cooperativity, where the lower toxin 
concentrations enhance and higher concentrations decrease the binding of the 
antitoxin to the promoter (Loris & Garcia-Pino, 2014). 
To study transcriptional regulation of the graTA system, I measured the 
graTA promoter activity by using a reporter gene lacZ. As a significant increase 
in the expression from the graTA promoter was seen in the ΔgraA strain (Ref I, 
Fig 4A), the GraA protein was confirmed to act as an autorepressor. DNase I 
Footprint analysis indicated that the regulation was achieved by direct binding 
of GraA to the graTA promoter DNA (Ref I, Fig 4C). The absence of GraT 
resulted in slightly stronger repression of transcription compared to wild-type, 
suggesting that GraT might act as a derepressor of the operon (Ref I, Fig 4A). 
Yet, the DNase I Footprint analysis did not support this idea, as the antitoxin 
and the TA complex were needed in almost similar amounts to produce the 
DNase I-protected area on the operator DNA (Ref I, Fig 4C). 
To figure out the action of the toxin in the regulation of graTA expression, 
the binding of GraA and the GraTA complex to DNA was analysed by 
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isothermal titration calorimetry (ITC). The results showed a high affinity for the 
binding between the GraA and DNA (KD=200 nM) (Fig 11A), which is quite 
similar to some other TA antitoxins (Wen, et al., 2014). Yet, determining the 
thermodynamic parameters of GraA binding to graTA operator region showed 
also an unexpected result. Commonly, one type II antitoxin dimer binds to one 
palindromic sequence of a DNA molecule (Brown, et al., 2011, Wen, et al., 
2014, Zorzini, et al., 2015), and we had found one palindromic sequence from 
the operator region of graTA (Ref I, Fig 4B). Thus, we expected to see that one 
GraA dimer binds to the promoter. However, ITC results showed that two GraA 
dimers bind to the graTA operator DNA to repress the expression from the 
graTA locus (Fig 11A). 
 
 
Figure 11. The ITC curves of GraA and GraTA binding to DNA. A: 90 μM of GraTA 
operator DNA was titrated into 20 μM of GraA. B: 989 μM GraTA operator DNA was 
titrated into 165 μM of GraTA. The upper panels show the raw injection heats, the 
lower panels, the corresponding binding isotherms. The dissociation constants and 
molar ratio of the binding of the proteins and DNA are indicated (Talavera, Tamman et 
al., unpublished). 
 
From the footprinting data we had presumed that GraT does not essentially 
influence the DNA-binding ability of the antitoxin (Ref I, Fig 4C). Yet, the 
thermodynamic parameters of the binding between GraTA complex and DNA 
surprisingly showed that the affinity of the GraTA complex to DNA is over 
three orders of magnitude lower than for GraA antitoxin alone (Fig 11B). 
Moreover, the binding of GraTA complex to DNA is so low that the precise 
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binding affinity cannot be determined. Thus, the ITC data showed that the toxin 
inhibits the DNA binding of GraA (Fig 11B), indicating that GraT acts as a 
derepressor in graTA regulation. The discrepancy between the GraTA complex 
binding ability in footprinting and ITC analysis is not easy to explain. Still, one 
may speculate that DNA cleavage by DNase I may somehow stabilize the 
GraTA binding to the operator in the footprint experiment (Ref I, Fig 4C). In 
spite of this discrepancy, both in vitro analyses show that, differently from what 
is reported on many TA systems, graTA is not regulated by conditional 
cooperativity. Rather GraA alone is a repressor of graTA expression while the 
toxin acts as a derepressor only. 
Although the in vivo transcriptional regulation measurements in P. putida 
also indicated that the toxin might be a derepressor, there was only a slight 
difference in β-galactosidase activities between the wild-type and the ΔgraT 
derivative (Ref I, Fig. 4A). Thus, to further analyse the effect of the GraTA 
proteins on their promoter activity in vivo, I performed the β-galactosidase 
activity measurements in E. coli, so that the chromosomal graTA genes could 
not influence the obtained results. I used a two-plasmid system: the graTA-lacZ 
transcriptional fusion was encoded by the plasmid p9TT1586 (as in previous 
experiments in P. putida; Ref I, Fig 4A), and the GraA or GraTA proteins were 
expressed from the IPTG-inducible promoter in plasmids pBBR_GraA and 
pBBR_GraTA, respectively. In good accordance with the ITC data of GraA 
having a higher affinity to DNA than the GraTA complex, I found that GraA 
repressed the graTA promoter strongly, whereas almost no repression was 
caused by the complex (Fig 12A). 
Thus, our results suggest a mechanism for graTA transcriptional regulation, 
which differs from conditional cooperativity, where toxin can act both as 
corepressor and derepressor (Overgaard, et al., 2008, Garcia-Pino, et al., 2010, 
Cataudella, et al., 2012). In the regulation of graTA expression, GraT toxin is a 
derepressor only, resembling that of the MqsRA system, as the MqsR toxin also 
inhibits the antitoxin binding to mqsRA operator (Brown, et al., 2013). If GraA 
is in excess, it binds to the operator and efficiently represses the transcription 
from the graTA promoter. However, when the abundance of GraT increases and 
equals with that of the GraA, the GraTA complex is formed and due to its low 
DNA binding affinity, expression from the graTA is elevated. Thus, increased 
amount of toxin leads to a stronger expression of the graTA locus, including an 
increase in the synthesis of the antitoxin. Note, that when compared to 
conditional cooperativity, the outcome in response to toxin excess is quite 
similar: the graTA genes are derepressed and enhanced expression of the locus 
guarantees that antitoxin levels increase again and silence the toxin.  
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Figure 12. graTA operon is repressed only by GraA. A: Measurements of β-ga-
lactosidase activity in E. coli containing the plasmids p9TT1586 with graTA-lacZ 
transcriptional fusion and pBBR enabling the overexpression of GraTA proteins. The 
first bar represents the β-galactosidase activities in the presence of an empty pBBR 
vector. Second and third clusters of bars show the effects of GraA and GraTA 
(respectively) expressed from genes preceded by a strong Shine-Dalgarno (SD) from 
pET11c vector. The last cluster of bars represents the effect of GraTA expressed from 
its native SD (n-GraTA). B and C: Western blots using anti-GraA (B) or anti-GraT (C) 
antibodies to estimate the amount of expressed GraA or GraT, respectively. Coloured 
arrows show the bands of the Western blot corresponding to bars of the diagram. 
 
2.2. GraA is translated more efficiently than GraT 
In order for the TA system not to poison the cell, the antitoxin must be 
produced in a higher amount than the toxin. For most type II TA systems the 
antitoxin gene precedes the toxin gene in the operon, which is thought to result 
in a higher production of the antitoxin compared to the toxin. In the TA families 
with reversed operon structure, different options may be applied to achieve 
antitoxin’s efficient production. For example, some systems have an additional 
promoter inside the operon, in front of the antitoxin gene (Tian, et al., 1996b, 
Otsuka, et al., 2010). For graA an additional promoter could not be identified 
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with 5’-RACE analysis (Ref I). Thus, there should be another explanation for 
the efficient production of the antitoxin. 
Studying the transcriptional regulation of the graTA system in E. coli, I used 
a construct where the original Shine-Dalgarno (SD) sequence of the graTA 
genes was replaced with a strong SD from a pET plasmid (pBBR_GraTA and 
pBBR_GraA). This resulted in high expression of both proteins (Fig 12B and C) 
However, for expression of the GraTA complex I also used another plasmid, 
pBBR_n-GraTA, where the graTA genes retained their original upstream 
region, i.e. translation of both GraT and GraA originated from their native SD. 
Measuring the graTA promoter activity in the presence of pBBR_n-GraTA 
revealed largely different results from data obtained with pBBR_GraTA. While 
the expression of GraTA complex from the pBBR-GraTA resulted in clear 
derepression of transcription, the pBBR_n-GraTA construct allowed only 
partial activation of the graTA promoter (Fig 12A). To figure out what could be 
the reason for these conflicting results, the amount of the proteins was estimated 
by Western analysis using antibodies against the GraA or GraT proteins. Both 
proteins were detectable in high amounts when they were expressed from 
pBBR_GraTA (Fig 12B and C). However, when the GraTA proteins were 
expressed from pBBR_n-GraTA, I could only detect the antitoxin, but not the 
toxin on Western blot membranes (Fig 12B and C). For translation initiation, 
the ribosome binds to the SD sequence, commonly located about eight bases 
upstream of the start codon. The efficiency of protein synthesis largely depends 
on the ability of the SD of a particular gene to bind to the complementary 3’ end 
of 16S rRNA (Shine & Dalgarno, 1974). As our results show that the graTA 
promoter repression observed with the GraTA complex expressed from the 
native SD sequence resulted from a high amount of free antitoxin in the cells 
(Fig 12B and C), the SD sequence preceding graA must be stronger than that in 
front of graT in the native graTA locus. Thus, our data suggest that the higher 
antitoxin production is regulated not at the level of transcription, but rather at 
the translational level. These data are in line with the results reported for the 
HigBA system from the Rts-1 plasmid – the authors claim that when expressing 
the higBA genes in their native arrangement from the T7 promoter, only the 
HigA protein was detected (Tian, et al., 1996a). This kind of difference between 
the translation efficiency of the two TA proteins seems meaningful for TA 
systems with a reversed gene order, as it ensures increased production of the 
antitoxin over the toxin. The higher translation rate of the antitoxin would 
suffice to keep the antitoxin amount high enough for inactivation of the toxin 
even without the additional promoter for the antitoxin gene (Review of 
literature, chapter 2.2.1.1.). 
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2.3. GraA is an exceptionally stable protein (Ref II) 
Most type II antitoxins are labile proteins with half-lives of only around 15 
minutes (Review of literature, chapter 2.2.1.2). Considering the uncommonly 
efficient inactivation of the overexpressed GraT by the GraA antitoxin (Ref I, 
Fig 2B), it was tempting to speculate that GraA could be a quite stable protein. 
To control this hypothesis, the degradation rate of GraA was determined by 
incubating the purified antitoxin in the cell lysate of P. putida and monitoring 
the amount of GraA using Western blotting. The results showed that the 
degradation of GraA is very slow in cell lysates from P. putida grown at 
optimal growth conditions (rich broth, 30 °C) (Ref II, Fig 1). However, study of 
GraA degradation rate throughout the bacterial growth revealed that the stability 
of GraA decreases at the transition from exponential to stationary phase (Ref II, 
Fig 1) when bacteria adapt to lower nutrient levels and other disfavoured 
conditions. Although the stability of GraA decreased markedly, the half-life of 
the antitoxin still remained around one hour, which is roughly about four times 
higher compared to most type II antitoxins (Brzozowska & Zielenkiewicz, 
2013). Also, the energetic status of the cell is probably an important factor 
influencing the GraA degradation rate as addition of ATP to the degradation 
mixture stabilized GraA remarkably (Ref II, Fig 2A). 
The rapid degradation of antitoxins is usually instigated by the unstructured 
and flexible C-terminal part of the protein and carried out by major cellular 
stress-induced proteases Lon or ClpP (Brzozowska & Zielenkiewicz, 2013). 
These proteases recognize the unstructured part of the antitoxins and degrade 
them to oligopeptides (Sauer & Baker, 2011). Notably, GraA seems to have a 
more fixed structure (Fig 13). Also, the antitoxin stability was not altered by the 
deletion of either lon or clpP from P. putida genome (Ref II, Fig 2A). These 
results strongly suggest an entirely different regulation of GraA stability. 
Indeed, GraA degradation seems to be triggered by an endoprotease that cuts 
the antitoxin into two unequal parts at about the 80th position. These parts are 
afterwards probably individually directed to final degradation. The cleavage site 
was initially suggested by a small peptide appearing on Western blot mem-
branes during the GraA degradation (Ref II, Fig 1B and D) and further 
supported by site-directed mutagenesis. We mutated several amino acids in the 
vicinity of the 80th position and noticed that GraA(R80A) was more stable and 
GraA(L79A) more labile compared to wild-type GraA (Ref II, Fig 3). 
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Figure 13. The crystal structure of GraA dimer. One monomer is in purple, the other 
one in brown colour. The approximate position of the 80th amino-acid is marked with 
red arrows. The N- and C-terminus are marked on the brown monomer (Talavera, 
Tamman et al., unpublished). 
 
The increased lability of GraA(L79A) allowed us to carry out a transposon 
mutagenesis to search for regulators of GraA stability. We expressed the 
GraA(L79A) protein in the ∆graA mutant at such a low level that its degra-
dation rate exceeded its synthesis rate. Thus, it could not complement the lack 
of GraA unless it was stabilized by a transpositional disruption of a protease 
gene. The inability of ΔgraA bacteria to form colonies at 20 °C, was a con-
venient phenotype in the screen for the GraA-stabilizing mutants. Unexpec-
tedly, the transposon mutant screen did not lead to the discovery of the GraA-
degrading protease. Instead, the disruption of mexT, which codes for a LysR 
type transcriptional regulator, allowed colony formation of ΔgraA bacteria at 
20 °C. To test if MexT is indeed involved in the stability of GraA, the de-
gradation dynamics of GraA were analysed in the cell lysate of a mexT deletion 
strain. Given that the absence of MexT regulator increases the stability of GraA 
more than threefold (Ref II, Fig 4), MexT somehow contributes to GraA 
degradation. MexT has been extensively studied in P. aeruginosa, where it 
modulates virulence and tolerance to antibiotics (Tian, et al., 2009b, Fargier, et 
al., 2012). MexT of P. putida PaW85 is over 80% identical to its orthologue in 
P. aeruginosa (Winsor, et al., 2009), which suggests that the regulator has 
similar functions in these bacteria. Indeed, it has been shown that in both 
bacteria, MexT activates the expression of an efflux pump MexEF-OprN (Tian, 
et al., 2009a, Herrera, et al., 2010). Considering that MexT has many other 
target genes with still unknown functions (Tian, et al., 2009a), it is possible that 
the same conditions that activate MexT could trigger the degradation of GraA. 
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MexT has been shown to be activated under oxidative stress (Fargier, et al., 
2012), and indeed, the mexT deletion decreased the tolerance of P. putida to 
diamide, known to cause oxidative stress (Fig 14). Yet, when the graTA genes 
were deleted from the genome either together or individually, the diamide 
tolerance was not decreased compared to the wild-type (Fig 14). Therefore, the 
GraTA system is not important for oxidative stress tolerance in P. putida, at 
least under tested laboratory conditions. 
 
 
Figure 14. Oxidative stress tolerance of P. putida PaW85 (WT) and its graTA (∆graA, 
∆graTA and ∆graT) or mexT (∆mexT) deletion derivatives. Overnight cultures were 
serially diluted and spotted on LB plates containing 2 mM or 5 mM diamide and 
incubated for 44 h at 25 °C. Numbers above the pictures show the approximate amount 
of cells in each spot.  
 
2.4. A proposed model for the regulation of GraTA system 
The current study revealed several regulatory mechanisms that guarantee the 
silencing of GraT toxin under normal growth conditions. We propose the 
following regulation of the GraTA system in P. putida (Fig 15). Firstly, the 
expression of graTA genes is repressed in the excess amount of the antitoxin 
over the toxin (Ref I Fig 4A; Fig 12). Differently from several other TA systems, 
the GraT toxin acts as a derepressor only and no conditional cooperativity is 
involved in the graTA regulation. Secondly, though the antitoxin gene is the 
second one in the operon, the production of GraA is higher than that of the 
toxin, due to increased translation efficiency of the GraA-specific mRNA (Fig 
12). Thirdly, GraA is an unusually stable antitoxin, though several factors, 
including the growth phase, ATP levels, an unknown endoprotease and MexT 
regulator can affect its stability (Ref II). 
The most interesting question regarding the regulation of any TA system is 
how the activation of the toxin is achieved. Considering the high stability of the 
antitoxin GraA, we assume that the activation is caused by the degradation of 
GraA triggered at conditions that remain to be discovered. 
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Figure 15. Schematic representation of the regulation of the GraTA system. A: In 
unstressed conditions the expression of graTA genes is repressed by the antitoxin. From 
the small amount of mRNA that is still produced, the GraA antitoxin is translated more 
efficiently than the GraT toxin. GraA forms into a dimer and inhibits the toxin by 
binding two GraT monomers. B: Unknown stress conditions activate an unknown 
endoprotease that cuts GraA near the 80th position (marked with scissors), resulting in 
the degradation of GraA. In the lack of the antitoxin, GraT is free to attack its cellular 
target and the operon is derepressed. The operator region is green, toxin red and 
antitoxin blue. Transcription/translation is marked with an arrow (dotted line for weak 
and solid for strong efficiency). 
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In several regulatory aspects the GraTA system resembles the MqsRA 
system of E. coli. Just like for GraTA, the regulation of MqsRA does not include 
conditional cooperativity and the toxin MqsR acts solely as a derepressor of the 
TA operon (Brown, et al., 2013). Moreover, in the mqsRA locus, the toxin gene 
precedes the antitoxin gene and no additional promoter for antitoxin expression 
has been determined (Christensen-Dalsgaard, et al., 2010). Notably, both MqsA 
and GraA are quite stable antitoxins. One can hypothesize that to achieve an 
efficient amount of the MqsA antitoxin, it also needs higher translation 
efficiency as observed for GraA, but sadly, this has remained unstudied to date. 
Alike other TA systems, the trigger of MqsRA and GraTA systems, considering 
the liberation of MqsR or GraT toxins, is the increase in the degradation rate of 
antitoxins. Degradation of MqsA was shown to accelerate upon oxidative stress 
resulting in the activation of the system (Wang, et al., 2011). Unfortunately, the 
stress conditions that would lead to the destabilization of GraA and, thus, 
activation of GraT have not been determined. Nevertheless, stabilizing effect of 
ATP and involvement of MexT in GraA degradation could give decisive leads 
to ascertain the conditions of GraT activation (Ref II, Fig 6). 
 
 
3. The effect of GraT on translation involves  
the DnaK chaperone 
3.1. The GraT toxin inhibits ribosome biogenesis (Ref III) 
Temperature dependence is hardly ever associated with TA toxins. Only a few 
examples can be found: heat shock destabilizes the toxin mRNA of a type I 
system BsrG/SR4 (Jahn, et al., 2012) and activates the type II toxin YoeB 
(Janssen, et al., 2015). GraT, however, causes severe growth defects at reduced 
temperature. It can be that susceptibility of the GraT target is increased at lower 
temperature. As cold sensitivity of bacteria can be associated with disturbed 
ribosome biogenesis (Shajani, et al., 2011), and a majority of type II TA toxins 
target translation (Guglielmini & Van Melderen, 2011), the starting point for 
discovering the target of GraT was analysing the ribosome profiles of wild-type 
and ΔgraA strains of P. putida. The finding that bacteria with the active toxin 
(ΔgraA strain) contained a remarkably increased amount of free ribosomal 
subunits (Ref III, Fig 1) indicated that the toxin had disturbed the translational 
machinery. In accordance with the cold sensitivity of the ΔgraA strain, the 
accumulation of free subunits was more pronounced at low temperatures (Ref 
III, Fig 1). Further analysis of accumulating subunits by mapping the 5’ ends of 
rRNAs and studying nucleotide modifications, revealed that the subunits lacked 
the final processing (Ref III, Fig 2) and late-assembly specific modifications 
(Ref III, Fig 3), thereby proving that subunits were immature. These results 
show that GraT inflicts a ribosome biogenesis defect, which well coincides with 
the cold sensitivity of the ΔgraA strain. Considering that the cold sensitivity 
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often accompanies the defects in the ribosome biogenesis process, the increased 
effect of GraT at reduced temperature is probably explained by the higher 
vulnerability of the process it targets. Still, we cannot exclude the possibility that 
the GraT amount in cells is increased at reduced temperature, but as the 
antibodies against GraT are not sensitive enough, we have not been able to test it.  
What we have discovered about the toxin GraT is different from what is 
known about its closest relatives – the ribosome-dependent HigB mRNases of 
V. cholera and P. vulgaris. Firstly, GraT of P. putida is less toxic than chro-
mosomally encoded HigB of V. cholera, because graA can be deleted, but 
respective gene (higA) from V. cholerae cannot (Budde, et al., 2007). Secondly, 
GraT causes accumulation of free ribosomal subunits, while overexpression of 
P. vulgaris HigB does not result in this phenotype, rather the relative abundance 
of 70S monosomes increases (Hurley & Woychik, 2009). Third, in spite of 
several attempts, we have not been able to detect GraT on ribosomes, while 
HigB of P. vulgaris has been shown to associate with the ribosomal 50S subunit 
(Hurley & Woychik, 2009). Although these data suggest significant differences 
in the mechanism of action for distinct proteins of the same toxin family, we 
still wanted to find out if GraT could also be an mRNase similarly to its closest 
relatives. Unfortunately, we did not succeed in purifying the toxin for in vitro 
analysis of mRNase activity due to rapid precipitation of the GraT protein. We 
also do not have a stable plasmidial overexpression system for P. putida that 
would allow to study the in vivo effects of overexpressed toxin. Thus, we set out 
to find the target and precise mechanism of GraT’s action using a different 
approach. 
 
 
3.2. The toxicity of GraT is suppressed by the deletion  
of DnaK C-terminus (Ref III) 
To get insight into the mechanism of GraT and identify factors involved in its 
toxicity, I carried out one more transposon mutagenesis experiment. This time I 
used a transposon containing a lacItac cassette with the IPTG-inducible tac-
promoter directed towards the end of the transposon. This allows the transposon 
to be used for insertional activation as well as for inactivation of genes. The 
library of ΔgraA lacItac-transposon mutants was again screened for the ability 
of cells to form colonies at 20 °C. The plates contained IPTG to find genes 
that’s disruption or overexpression could suppress the growth defect of ΔgraA 
strain. We supposed that if a factor involved in GraT toxicity was disrupted or 
the target of the toxin induced, the cold-sensitive phenotype of cells would 
disappear and the colonies could form at 20 °C. Surprisingly, we could not find 
any mutants with their growth dependent on IPTG. Thus, rather the disruption 
and not the overexpression of some gene suppressed the growth inability of the 
ΔgraA strain. Closer analysis showed that the cold-sensitivity of growth inflicted 
by the GraT toxin was relieved by disruption of the most distal C-terminal part 
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of the molecular chaperone DnaK (Ref III, Fig 5A and B). Analysing the 
ribosome profile of these bacteria showed that ribosome biogenesis defect was 
suppressed as well (Ref III, Fig 5C). Considering that DnaK assists the late 
stages of ribosome assembly especially at suboptimal conditions (e.g. at high or 
low temperatures) (Maki, et al., 2002, Rene & Alix, 2011), these results further 
suggested that ribosome biogenesis is the process targeted by GraT. 
Next, we aimed to determine if GraT may directly interact with DnaK. The 
fact that His-tagged DnaK could pull down the tagless GraT from E. coli lysate 
confirmed a direct interaction between the two proteins (Ref III, Fig 6). 
Although the deletion of the C-terminus of DnaK suppressed GraT toxicity, the 
interaction between the proteins occurred regardless of the presence of the C-
terminal part of DnaK. These data are in line with previous studies, showing 
that the truncation of the distal part of the C-terminal lid-domain of DnaK does 
not influence its protein-binding ability (Swain, et al., 2006). However, as the 
pull-down assay is not a quantitative method for detecting the binding between 
two proteins, we cannot draw conclusions about the possible differences in the 
binding affinities of GraT and C-terminally truncated DnaK compared to GraT 
and intact DnaK. 
The direct interaction between GraT and DnaK suggests an important role of 
DnaK in GraT toxicity. Although we cannot completely exclude the possibility 
of GraT just out-titrating DnaK and causing chaperone limitation that inhibits 
ribosome biogenesis, this possibility seems highly unlikely. First, DnaK is 
abundant protein in bacteria (Calloni, et al., 2012) and it is not likely that GraT 
can be present in levels high enough to just titrate out the chaperone. As already 
mentioned before, we cannot detect native levels of GraT by Western analysis 
indicating that the GraT concentration in P. putida is low. Also, as a single 
point mutation in the toxin gene can abolish the GraT toxicity (Ref I, Fig 2C), it 
is not likely that this mutation can also abolish binding to DnaK (though this 
has not been tested experimentally). 
A much more plausible explanation is that the binding of GraT inhibits the 
chaperone activity of DnaK in facilitating ribosome biogenesis (Ref III, Fig 
7A). If DnaK was the direct target of GraT, the C-terminal deletion of DnaK 
should enhance its chaperone activity. This possibility would be in accordance 
with other studies that have suggested an increased ATPase activity (Slepenkov, 
et al., 2003) and refolding ability (Aponte, et al., 2010) for the C-terminally 
truncated DnaK. In this case, the deletion of the C-terminus of DnaK could 
possibly alleviate the effect of GraT by increasing the efficiency of the chaperone. 
On the other hand, considering that DnaK is a protein folding factor, the 
GraT-DnaK interaction might be important for the toxin to attain its active form 
and enable it to inflict its poisonous effect on its so far unknown target (Ref III, 
Fig 7B). Although Aponte et al. showed an increase in DnaK refolding ability 
upon C-terminal truncation (Aponte, et al., 2010), another study shows the 
opposite results (Smock, et al., 2011). Here, the authors suggest that the C-ter-
minal tail either contributes to the repeated binding of a peptide or facilitates 
53 
local unfolding of a misfolded substrate. Thus, if this was the case, the C-terminal 
part of DnaK would improve GraT’s folding, and upon its deletion, GraT may 
remain inactive. In this option, the direct target of GraT remains unclear. Still, 
the unpublished data from our laboratory suggest that GraT, alike other HigB 
family toxins, may act as an RNase (A. Ainelo, personal communication). In 
accordance with that, it was recently reported that the GraT orthologue in P. aeru-
ginosa PA14 has an RNase activity upon overexpression in E. coli (Wood & 
Wood, 2016). Thus, the possibility of GraT’s ability to cleave RNA is quite 
probable, but considering GraT’s moderate toxicity and other abovementioned 
differences between HigB and GraT, the set of targeted RNAs might be 
restricted to only a few, possibly of some ribosome-biogenesis factors, instead 
of a global mRNA cleavage as carried out by HigB (Hurley & Woychik, 2009). 
This would not be the first report of proteins from one family having distinct 
targets. The proteins belonging to the MazF toxin family have been shown to 
have several different ways of inhibiting translation. They can carry out 
universal mRNA degradation by having a short recognition sequence (Zhang, et 
al., 2003) or longer recognition sites, resulting in cleavage of more specific set 
of mRNAs (Zhu, et al., 2009, Rothenbacher, et al., 2012) or even cut tRNA or 
rRNA (Schifano & Woychik, 2014, Schifano, et al., 2016) (Review of 
literature, chapter 2.2.2.). Therefore, it is not surprizing if GraT has a different 
and maybe more specific target(s) compared to the quite non-specific HigB 
mRNase (Hurley & Woychik, 2009).  
 
 
4. The importance of the GraTA system  
for P. putida (Ref I) 
The wide distribution of GraTA orthologues in Pseudomonas spp. suggests the 
importance of this TA system for these bacteria. Yet, the conditions promoting 
antitoxin’s degradation and subsequent system activation have remained 
ambiguous. Considering the involvement of TA systems in stress management 
(Gerdes, et al., 2005, Starosta, et al., 2014) (Review of literature, chapter 4.2.), 
the abundance of GraTA orthologues in genomes of pseudomonads may indicate 
its contribution to coping with different stresses. This led us to study the role of 
GraT toxin in the stress tolerance of P. putida. 
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4.1. GraT plays a controversial role in the stress  
management of P. putida 
The stress-relieving effect of GraT was first suggested by the mutant screening 
where the GraTA system was initially identified. The antitoxin gene was iso-
lated as a gene that’s disruption led to the suppression of defects caused by ColR 
deficiency (Putrinš, et al., 2011). Lack of ColR decreases membrane integrity of 
bacteria, resulting in the lysis of a subpopulation on glucose medium. The latter 
phenotype can be determined by the leakage of DNA or β-galactosidase, the 
binding of Congo Red dye and studying the population structure with flow 
cytometry (Putrinš, et al., 2008, Putrinš, et al., 2010). Moreover, the colR-
deficient bacteria also have a reduced tolerance to phenol (Kivistik, et al., 2006) 
and to high concentration of various metals (Ainsaar, et al., 2014). 
The ability of graA disruption to suppress the ColR deficiency was first 
identified by reduced Congo Red binding and decreased leakage of β-galactosi-
dase (Putrinš, et al., 2011). and additionally confirmed with flow cytometry of 
the deletion mutants of the graTA system (Ref I, Fig 5A and B). To study if the 
deletion of the antitoxin suppressed other colR-deficiency-caused effects as 
well, we tested if the antitoxin deletion alleviated the colR mutant’s sensitivity 
to phenol (Kivistik, et al., 2006) (Ref I, Fig 6). Single cell analysis showed that 
the disruption of graA abolished cell death, and moreover, it also suppressed the 
phenol-sensitivity caused by the lack of ColR. These results illustrate nicely the 
stress-relieving effect of the toxin (Ref I, Fig 5A and Fig 6). GraT reduces the 
growth rate of bacteria and slower growth is known to support bacterial stress 
tolerance (Tuomanen, et al., 1986, Eng, et al., 1991). Thus, it seems logical to 
consider the growth rate reduction to be the main reason for the improved stress 
tolerance of the colR-deficient P. putida. 
The discovery of GraTA system closely resembles another study that 
reported a mutational inactivation of an antitoxin gene hicB leading to the 
suppression of lethality caused by the deficiency of rpoE (Button, et al., 2007, 
Daimon, et al., 2015). The rpoE gene codes for an alternative sigma factor σE that 
regulates a set of genes required to overcome membrane stress and ensure 
proper folding of membrane proteins (Erickson & Gross, 1989). In E. coli, the 
rpoE gene cannot be deleted, but inactivation of the hicB antitoxin gene 
suppressed the σE-essentiality (Daimon, et al., 2015). As was the case with 
GraTA, the reason of the suppression was the activation of HicA toxin. 
Moreover, one genomic copy of hicA did not inflict any significant growth 
impairment (Daimon, et al., 2015) meaning that the beneficial effects of HicA 
and GraT toxins on bacteria can be seen even upon a slight decrease in growth 
rate. The envelope stress of σE defective cells was also alleviated by expression 
of HigB and YafQ toxins, but the inactivation of the cognate antitoxins did not 
4.1.1. GraT suppresses membrane stress of colR-deficient  
bacteria (Ref I) 
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have the same effect. The authors proposed that the effect of these chromosomal 
toxins were too weak (Daimon, et al., 2015), which suggests that these toxins 
are even less toxic than GraT. Nevertheless, these data highlight the potential of 
TA systems to contribute to cell envelope stress management of bacteria. 
 
The effect of GraT under different stress conditions was tested by analysing the 
growth ability of P. putida wild-type and its graTA deletion derivatives on agar 
plates containing different antimicrobials (Ref I, Fig 7). ΔgraA cells grew better 
than the wild-type in the presence of various stress-inducers, which shows that 
GraT increases the tolerance to several of the tested chemicals. For example, the 
tolerance to translation inhibitors streptomycin and kanamycin and DNA 
damaging agents such as ciprofloxacin and mitomycin C is increased by the 
GraT toxin (Ref I, Fig 7).  
Many TA loci increase the number of persisters, and thus, also the ability of 
bacteria to survive the lethal effect of antibiotics (Dörr, et al., 2010, Maison-
neuve, et al., 2011). In order to test if GraT can increase the survival of bacteria 
during such treatment, the exponentially growing cultures of wild-type 
P. putida and the ΔgraA derivative were treated with a lethal concentration of 
streptomycin. Considering that the effects of GraT are cold-sensitive, the 
experiment was performed with bacteria grown at different temperatures. The 
killing curves clearly showed that lethality of streptomycin was reduced for 
ΔgraA mutant at 25 °C (Ref I, Fig 8A), thus the amount of persister cells was 
increased by GraT. In good agreement with the cold-sensitive growth suppres-
sion by GraT, the increased persistence of ΔgraA strain was observable only at 
temperatures below the optimal 30 °C (Ref I, Fig 8B). We suggest that GraT-
caused growth reduction could be responsible for the improved persistence of 
ΔgraA strain to antibiotic treatment. 
 
4.1.3. GraT increases biofilm formation 
Several TA systems are suggested to increase stress tolerance of bacteria by 
facilitating biofilm formation (Wang & Wood, 2011, Thomason, et al., 2012) 
whereas respective mechanisms are quite different (Review of literature, chapter 
4.2.2.). As GraT influenced the stress tolerance of P. putida, the involvement of 
the GraTA system in biofilm formation was studied as well. Quantification of 
biofilm at different temperatures revealed that at 25 °C the ΔgraA strain pro-
duced significantly more biofilm than the wild-type or ΔgraTA strain (Fig 16). 
In accordance with the cold sensitivity of the GraT-caused effects, the difference 
between the wild-type and the ΔgraA in biofilm formation disappeared at 
temperatures above 25 °C. These data show that GraT increases biofilm 
production in P. putida in a temperature-dependent manner.  
4.1.2. GraT has a potential to defend P. putida against different 
stress inducers (Ref I) 
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Figure 16. Biofilm formation of P. putida wild-type (WT) and its graA and graTA 
deletion derivatives (ΔgraA and ΔgraTA). Biofilm formation at A: 30 °C, B: 25 °C. 
Cells were grown statically in LB for 48 h. Error bars show the 95% confidence 
intervals. 
The positive impact of GraT on biofilm formation is in accordance with the 
results reported for many other TA systems (Kim, et al., 2009). However, 
conflicting results regarding biofilm formation were reported for an orthologue 
of the GraTA system of P. aeruginosa PA14, named HigBA (Wood & Wood, 
2016). If the antitoxin gene higA was deleted from P. aeruginosa, the HigB 
toxin was seen to reduce P. aeruginosa biofilm more than 10-fold (Wood & 
Wood, 2016). One possibility for this discrepancy may be that regardless of the 
similarity of these two TA systems [69.6 % of identity between the toxins GraT 
and its P. aeruginosa orthologue HigB (Ref I, Table S2)], they are not identical 
and thus could have disparate ways of influencing biofilm formation. 
Alternatively, the opposite results could have been obtained due to somewhat 
different experimental conditions: in our experiment, the temperature was 25 
and 30 °C instead of 37 °C that was used for P. aeruginosa. Moreover, we used 
lysogeny broth (LB), whereas Wood et al. measured biofilm in M9 medium 
with added amino acids (Wood & Wood, 2016). Although growth conditions 
can essentially affect the biofilm formation (Uhlich, et al., 2014), it is still 
remarkable that two homologous TA systems would influence the formation of 
biofilm in entirely opposite directions. However, the biofilm formation of 
P. putida and P. aeruginosa is regulated in quite different ways (Fazli, et al., 
2014). For example, the supposedly most important protein in biofilm formation 
of P. putida, the large adhesion protein LapA (Gjermansen, et al., 2010), is 
absent from P. aeruginosa (Duque, et al., 2013). Conversely, quorum sensing 
controlled by LasIR and RhlRI systems plays an important role in the biofilm 
formation of P. aeruginosa (Davies, et al., 1998), but not in P. putida (Fazli, et 
al., 2014). Furthermore, the overall involvement of TA systems in biofilm 
formation is quite complex and a straightforward view of the role that the toxins 
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play has not been determined (Review of literature, chapter 4.2.2.). Thus, it can 
indeed be possible that similar TA systems in similar (but not identical) 
conditions could have opposite effects. 
 
 
4.1.4. Costs of activation of GraT (Ref I) 
While many results have indicated that GraT is able to contribute to the stress 
tolerance of P. putida, several other data suggest that the GraT-mediated stress 
protection is costly and has harmful side effects. Analysis of the population 
structure of graTA deletion mutants at a single cell level resulted in an un-
expected outcome. Although the deletion of the antitoxin gene suppressed the 
lysis of the colR mutant, the membrane permeability of ΔgraA cells was 
remarkably increased in both wild-type and colR-deficient backgrounds. The 
membrane damage caused by the absence of ColR is glucose-specific (Putrinš, 
et al., 2008), yet GraT increases membrane permeability regardless of the 
growth medium (Ref I, Fig 5A and B). These data show that the active GraT 
also causes membrane defects, yet, can still eliminate the cell death caused by 
the absence of ColR. 
The other indication that the activation of GraT can be costly for bacteria, 
comes from the experiments conducted to evaluate the stress-relieving ability of 
GraT. The obtained data showed that although GraT increased the tolerance to 
many stress inducers (Ref I, Fig 7), it sensitized them to others. For example, 
ΔgraA mutant is more sensitive to osmotic stress caused by excess of NaCl (Ref 
I, Fig 7). The decreased tolerance to osmotic stress is a clear indication of 
impaired membrane functions. The other antimicrobials that had a more severe 
effect on ΔgraA than on wild-type were tetracycline and paraquat. Tetracycline 
targets the 30S subunit of the ribosome and paraquat causes oxidative stress and 
damages DNA. The increased susceptibility of ΔgraA cells to these distinct 
compounds could be caused by their easier entry into the cells, resulting from 
the damaged membrane. 
Similar dual effect of TA toxins has been observed by others as well. RelE 
family toxins from Salmonella Typhimurium increased bacterial tolerance to 
ciprofloxacin (Silva-Herzog, et al., 2015), but at the same time decreased 
tolerance to acidic conditions (pH 3) (Silva-Herzog, et al., 2015). Also, the 
deletion of toxin ndoA gene from Bacillus subtilis rendered the cells more 
susceptible to high temperatures and nutrient limitation, and conversely 
increased the tolerance to different antibiotics (kanamycin and moxifloxacin) 
and hydrogen peroxide (Wu, et al., 2011). Moreover, opposite effects of NdoA 
toxin absence has been observed under UV irradiation: lack of the toxin 
decreased the tolerance upon weak, but increased the tolerance upon stronger 
UV stress (Wu, et al., 2011). 
Bearing in mind the controversial effects of TA toxins, it seems very 
important that their activation should occur under certain conditions only, as the 
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uncontrolled activation of the toxins can be costly and in case of GraT, for 
example, result in membrane defects and decreased tolerance to several stress 
conditions. 
 
 
4.2. The possible physiological role of the GraTA  
system for P. putida 
Although GraT has a potential to influence the stress tolerance of P. putida, we 
have not detected physiological effects after the removal of the entire graTA 
locus: neither biofilm formation (Fig 16) nor growth under different stress 
conditions (Ref I, Fig 7) was affected. This suggests a strict control of the 
toxin’s activation in wild-type cells. Nevertheless, the effect of the deletion of 
the graTA system could be only subtle and may therefore remain unnoticed. In 
order to test if the GraTA system could give any growth advantages (or 
disadvantages) to P. putida, I analysed the competitiveness of the ΔgraTA strain 
by co-cultivating this strain with the wild-type. The cultures were mixed in 1:1 
ratio and re-inoculated into a fresh medium after 24 h of growth. Before each 
reinoculation a sample from the mixed culture was taken and the changes in the 
ratio of the two subpopulations were determined by locus-specific PCR. As 
neither of the two subpopulations could outcompete the other during seven days 
of experiment (Fig 17), we conclude that the system does not incur fitness 
benefits or costs for P. putida in growth-favouring conditions. As TA systems 
are considered to be more important under non-optimal and growth-limiting 
conditions, we also tested the competing ability of the ΔgraTA strain at 
different temperatures (20, 25, 37 °C) and in minimal media. Again, we saw no 
effect of GraTA system deletion on the competing ability of the bacteria in any 
of the tested conditions (data not shown). 
 
Figure 17. Deletion of the GraTA system does not affect the competitiveness of 
P. putida under optimal growth conditions. A: Calibration of PCR on different mixtures 
of P. putida wild-type (WT) and its graTA deletion derivative (ΔgraTA). The numbers 
above each panel indicate the ratio of two strains (WT:ΔgraTA) in the bacterial 
mixtures. PCR was carried out from the mixtures with primers specific for the graTA 
locus. B: Co-cultivation of P. putida wild-type and ΔgraTA strains (LB, 30 °C). The 
ratio of each subpopulation was determined by graTA locus-specific PCR every day 
(indicated by numbers above the panel) for a week. A representative picture of more 
than three experiments is shown. M represents the DNA size marker and numbers to the 
right of both figures show the sizes of the marker bands (bp). 
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It is quite common for bacteria with numerous TA systems to disclose no 
observable effects upon a deletion of a single TA locus (Tsilibaris, et al., 2007, 
Maisonneuve, et al., 2011). Yet, even if the absence of one system displays no 
effects, deleting multiple TA systems consecutively has increasingly stronger 
effects on persister formation in E. coli (Maisonneuve, et al., 2011). Our 
preliminary results do not confirm the same trend for P. putida. Deletion of 9 
out of the 15 predicted TA systems did not influence persister formation or 
competitiveness of P. putida under the conditions tested (similar as described 
above, data not shown). Thus, in P. putida the redundancy between the TA 
systems is probably not the reason for the lack of phenotypic effects in the 
graTA deletion strain. 
The other possible explanation could be that the graTA system has not been 
studied in appropriate conditions to reveal the effects on fitness of P. putida. In 
wild-type P. putida the GraA antitoxin can very efficiently avoid the toxin acti-
vation under the conditions we have applied. Thus, the absence of effects of the 
graTA deletion can be merely blamed upon our insufficient knowledge about 
the exact activating conditions of GraA degradation and, thus, the activation of 
the GraTA system. 
Gene expression of P. putida differs markedly between laboratory and envi-
ronmental conditions (Morimoto, et al., 2016), where bacteria face constant 
stress and nutrient limitation. Even if we use suboptimal conditions in the 
laboratory, they still remain quite growth-favouring compared to the environ-
mental ones. Moreover, in microbial communities consisting of bacteria from 
very different species there is a constant need to compete with other bacterial 
species inhabiting the same niche (Foster & Bell, 2012), which is also a factor 
influencing the physiology of environmental bacteria (Morris, et al., 2008, 
Stewart, 2012). Taken together, the set of conditions in natural habitats are very 
difficult to replicate in the laboratory. Nevertheless, the discovery of the con-
ditions that could trigger the degradation of GraA should be the main goal in the 
future studies. This could eventually lead to discovering the activating con-
ditions of GraTA system and thus shed more light to the importance of this 
quite uncommon TA system in the physiology of P. putida. 
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CONCLUSIONS 
The involvement of bacterial TA systems in stress survival has made them a 
popular topic of research. In recent years, an increasing number of chromo-
somal TA systems are characterized in various bacterial species, yet the 
research on these systems in the highly diverse Pseudomonas genus has 
remained scarce. Thus, the current work set out to describe the first TA system 
in this genus of bacteria. Respective P. putida system was named GraTA for the 
growth-rate-affecting ability of the toxin. The main features of the system can 
be summarized as follows: 
• The toxin GraT has moderate effects on bacterial growth at optimal 
growth conditions, yet causes a severe growth defect at reduced temperatures. 
GraT inhibits ribosome biogenesis and its toxicity needs the full-length DnaK 
chaperone. 
• The GraT toxin has a potential to contribute to the stress tolerance of P. 
putida, as it 
o increases the tolerance to several antimicrobials, 
o decreases lethal effects of antibiotics, 
o increases the biofilm formation. 
• Besides beneficial effects on stress tolerance, the activity of GraT has 
harmful side effects as it causes membrane impairment and decreased survival 
under certain stress conditions. 
• The potentially harmful toxin is under a strict control of the antitoxin GraA: 
o GraA autorepresses the graTA operon, whereas the toxin GraT acts as a 
derepressor when bound to GraA. 
o GraA counteracts GraT by forming a protein complex, where the toxin is 
inactive. 
o GraA is an unusually stable antitoxin, degradation of which is probably 
initiated by an endoproteolytic cleavage. The degradation rate of GraA 
depends on the growth phase of bacteria, energetic status of the cell and 
the transcription regulator MexT. 
• GraT is most probably activated by the accelerated degradation of GraA 
antitoxin in response to certain (yet unknown) stress conditions. 
The results of the current thesis show that the GraT toxin can both increase and 
decrease the stress tolerance of P. putida. However, GraT is only conditionally 
toxic and is kept under an uncommonly strict control by the highly stable GraA 
antitoxin. One may hypothesize that evolution has shaped the chromosomal 
toxins to be less toxic and increased the inhibiting ability of the antitoxins to 
reduce the possible harmful effects of the toxins to the host bacterium. Also, it 
seems that the activation of the potentially damaging GraTA system is needed 
only in a narrow range of conditions. Identification of these conditions is crucial 
to understand the importance of GraTA system in the physiology and stress 
tolerance of P. putida. 
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SUMMARY IN ESTONIAN 
Pseudomonas putida toksiin-antitoksiin süsteem GraTA: 
regulatsioon ja osalus stressitaluvuses 
Bakteriaalsed toksiin-antitoksiin (TA) süsteemid koosnevad reeglina kahest osa-
poolest – raku elutegevust pärssivast toksiinist ja teda neutraliseerivast anti-
toksiinist. Kui toksiin on alati valk, siis antitoksiini funktsiooni võib täita nii 
valk kui ka sRNA. Antitoksiin võib takistada nii toksiini ekspressiooni, aktiiv-
sust kui ka stabiilsust ning leidub ka selliseid antitoksiine, mis kaitsevad toksiini 
rakulist märklauda (Page & Peti, 2016). Käesolev töö käsitleb põhjalikumalt II 
tüüpi TA-süsteeme, milles nii toksiin kui antitoksiin on valgud ja toksiini 
inaktiveerimine toimub kahe valgu omavahelisel seondumisel (Gerdes, et al., 
2005). 
Kuna TA-süsteemid kodeerivad rakule toksilist valku, siis pole sugugi üllatav, 
et neid süsteeme reguleeritakse mitmel eri tasandil. TA-operoni ekspressiooni 
autoreguleerib enamasti antitoksiin ja/või TA-kompleks. Toksiin võib, olenevalt 
tema suhtelisest hulgast antitoksiini suhtes, kas suurendada või vähendada TA-
kompleksi seondumist TA-geenide operaatorpiirkonnale ja sel viisil põhjustada 
nii TA-geenide repressiooni kui ka derepressiooni (Loris & Garcia-Pino, 2014). 
TA-süsteemide II tüübi puhul on teiseks regulatsiooniastmeks antitoksiini sta-
biilsuse reguleerimine. Antitoksiinid on tavaliselt väga labiilsed valgud (nende 
pooleluiga on harilikult ligikaudu 15 minutit), mille lagundajateks on enamasti 
rakulised Lon või Clp proteaasid (Kedzierska & Hayes, 2016). Samas on anti-
toksiinide lagundamise regulatsioon TA-süsteemide aktiveerumisel oluline 
etapp, kuna ainult seeläbi saab toimuda toksiini valgu aktiveerumine. 
Esmalt avastati TA-süsteemid väikese koopiaarvuga plasmiididest, kus nad 
on olulised tagamaks plasmiidi säilimist bakteripopulatsioonis (Gerdes, et al., 
1986a). Plasmiidiga rakus toodetakse nii toksiini kui antitoksiini, mistõttu 
toksiin on vaigistatud. Kuigi antitoksiini lagunemine on kiire, toodetakse seda 
plasmiidilt juurde ja toksiin jääb inaktiivsesse olekusse. Kui aga raku jagu-
nemisel ei peaks tütarrakku plasmiidi kanduma, katkeb antitoksiini juurde-
süntees, mis viib tsütoplasmas leiduva toksiini aktiveerumisele ja bakteri kasvu 
pärssimisele. See annab kasvueelise plasmiidi sisaldavatele bakteritele ja 
plasmiidi kaotanud rakud kõrvaldatakse populatsioonist. 
Seoses mikroobide täisgenoomide sekveneerimisega ilmnes, et TA-
süsteemid on üllatavalt laialt levinud ka paljude bakterite kromosoomides. Kui 
plasmiidsete TA-süsteemide funktsioon on üsna üheselt mõistetav, siis bakteri 
kromosoomis leiduvate potentsiaalselt toksilisi valke kodeerivate geenide 
olemasolu põhjustas arusaadavalt poleemikat nende geenide rollist bakteri bio-
loogias. Viimase aja uuringud on aga tuvastanud kromosomaalsete TA-süs-
teemide seotuse bakterite stressivastusega (Gerdes, et al., 2005). Seda näitab nii 
TA-süsteemide otsene osalus üldistes stressivastustes kui ka nende olulisus 
faagivastases kaitses, biofilmi moodustumises, persistorrakkude tekkes ja 
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kasvuregulatsioonis. Kromosomaalsete TA-süsteemide olulisust bakteri stressi-
taluvuses peegeldab ka nende ebaühtlane jaotus erinevaid nišše asustavate bak-
terite genoomides. TA-süsteeme on väga palju muutlikke ja stressirohkeid 
keskkondi asustavatel bakteritel, samas kui rakusiseste parasiitide genoomis ei 
ole sageli ühtegi TA-süsteemi (Pandey & Gerdes, 2005, Leplae, et al., 2011). 
Arvatakse, et stabiilsetes tingimustes kaotavad need süsteemid oma tähtsuse ja 
neid kodeerivad geenid kaovad kromosoomist.  
Palju erinevaid keskkondi asustava Pseudomonas’e perekonna bakterites ei 
ole neid stressi talumises olulisi süsteeme väga põhjalikult uuritud, kuigi kõik 
selle perekonna bakterid kodeerivad ennustuse järgi vähemalt paari TA-süsteemi 
(Shao, et al., 2011). Käesoleva töö eesmärk oli iseloomustada keskkonnabakter 
Pseudomonas putida oletatavat TA-süsteemi ja uurida selle TA-mooduli rolli 
bakteri stressitaluvuses. Eelnev teadmine, et selle TA-süsteemi antitoksiini geeni 
(PP1585) katkestus leevendab P. putida membraanistressi (Putrinš, et al., 2011), 
tekitas küsimuse, kas stressi leevenemise põhjuseks on geeni PP1585 katkestus 
või selle tulemusel aktiveeruv toksiin (PP1586). Selgus, et membraanistressi 
vähendas aktiveerunud toksiin ja et PP1586-PP1585 lookus kodeerib funktsio-
naalset TA süsteemi, mille nimetasime kasvukiiruse regulatsioonis osalemise 
tõttu GraTA (growth-rate-affecting) süsteemiks. GraTA süsteemi peamised 
omadused saab kokku võtta järgnevalt: 
• Kui tavatingimustel on GraT toksiin üsna mõõduka toksilisusega, siis 
madalal temperatuuril aeglustab toksiin tugevalt bakteri kasvu, kuna 
inhibeerib ribosoomi biogeneesi. GraT toksilisuse avaldumiseks on vajalik 
täispika DnaK šaperoni olemasolu. 
• GraT toetab P. putida stressitaluvusest, sest ta: 
o suurendab tolerantsust erinevate kemikaalide suhtes, 
o vähendab antibiootikumide surmavat toimet, 
o suurendab P. putida biofilmi tootmist. 
• Kuigi GraT on mitmetes stressitingimustes kasulik, võib selle toksiini kont-
rollimatu aktivatsioon olla kahjulik, sest GraT kahjustab bakterimembraani 
ja muudab bakterid mitme stressi suhtes tundlikumaks. 
• Antitoksiin GraA vaigistab efektiivselt potentsiaalselt kahjulikku GraT 
toksiini: 
o GraA represseerib graTA operoni avaldumist, kusjuures GraT pärsib 
GraA seondumist DNAle. 
o GraA dimeer moodustab kahe toksiini monomeeriga kompleksi, milles 
GraT on inaktiivne. 
o GraA on ebaharilikult stabiilne valk, mille lagunemise algatab arvatavasti 
endoproteolüütiline lõikus 80. aminohappe juurest. GraA lagunemiskiirus 
sõltub bakteri kasvufaasist, kuid ka raku energeetilisest staatusest ja 
transkriptsiooniregulaatorist MexT. 
• Oletatavalt on GraTA süsteemi päästikuks GraA kiirenenud lagunemine seni 
teadmata tingimustel. 
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Käesoleva töö tulemused näitavad, et GraT osaleb P. putida stressivastuses, 
kuid sõltuvalt tingimustest võib toksiini mõju olla bakterile nii kasulik kui ka 
kahjulik. Seda arvestades ei ole üllatav, et GraA on ebatavaliselt stabiilne ja 
efektiivne toksiini neutraliseerimisel. Kromosomaalsete toksiinide aktivatsiooni 
potentsiaalset kahjulikkust silmas pidades võib oletada, et TA toksiinid evo-
lutsioneeruvadki mõõdukuse ja antitoksiinid tõhususe ja stabiilsuse suunas, et 
toksiinide võimalikku kahju minimeerida. Töös esitatud tulemustele tuginedes 
võib arvata, et tingimused, milles GraT vabaneb GraA neutraliseeriva mõju alt, 
on üsna spetsiifilised. Nende edaspidine tuvastamine on oluline, et mõista 
GraTA süsteemi olulisust keskkonnabakteri P. putida füsioloogias ja stressi-
taluvuses. 
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